Secondary bacterial infections associated with influenza pandemics
Open accessAbstract
Lower and upper respiratory infections are the fourth highest cause of global mortality (Lozano et al., 2012). Epidemic and pandemic outbreaks of respiratory infection are a major medical concern, often causing considerable disease and a high death toll, typically over a relatively short period of time. Influenza is a major cause of epidemic and pandemic infection. Bacterial co/secondary infection further increases morbidity and mortality of influenza infection, with Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus reported as the most common causes. With increased antibiotic resistance and vaccine evasion it is important to monitor the epidemiology of pathogens in circulation to inform clinical treatment and development, particularly in the setting of an influenza epidemic/pandemic.
AI snapshot
Written from the paper’s full text.
TL;DR
This narrative review concludes that bacterial co/secondary infections, most commonly Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus, substantially increased morbidity and mortality during influenza pandemics since the late 1800s. It synthesizes historical and contemporary evidence on mechanisms, epidemiology, and pandemic-specific bacterial complications.
Key findings
- Bacterial co/secondary infection is frequent and severe: up to 75% of influenza patients who acquire pneumonia have confirmed bacterial co-infection; up to 65% of laboratory-confirmed influenza cases showed bacterial co/secondary infection, although a cited meta-analysis found most estimates between 11% and 35%.
- The most commonly reported bacteria in influenza pandemics since the late 1800s are S. pneumoniae, H. influenzae, and S. aureus; S. pneumoniae is described as the most common bacterial cause in viral secondary infections.
- Historical pandemic burden: 1918 A(H1N1) infected 50% of the world’s population and caused 40–50 million deaths, with bacterial pneumonia estimated in up to 95% of deaths; 1957 A(H2N2) caused 1.5–4 million global deaths and 69,800 US deaths, with bacterial infection in up to 80% of severe/fatal cases; 1968 A(H3N2) caused 1–2 million global deaths and 33,800 US deaths; 2009 A(H1N1) caused about 284,000 deaths worldwide, with secondary bacterial pneumonia identified in 29–55% of mortalities.
- Mechanisms include influenza-induced epithelial damage, increased bacterial adhesion/colonization, impaired immune clearance, and in some cases bacterial proteases cleaving influenza HA; timing matters, as H. influenzae co-infection showed high lethality when introduced 3–4 days apart but not simultaneously or 7+ days later.
Methods
- Design: narrative review of influenza pandemics since the late 1800s and associated bacterial co/secondary infections.
- Data: published laboratory, clinical, epidemiological, and historical literature, including a table of significant pandemics (1889, 1918, 1957–1958, 1968–1969, 1977–1978, 2009) and cited animal and human studies.
- Analysis: qualitative synthesis of evidence on pathogens, mechanisms, pandemic-specific bacterial complications, and factors affecting severity; no systematic search or meta-analysis described.
Limitations
- The paper states uncertainty about whether Moraxella catarrhalis was truly absent or rare in early pandemics or was missed because it was not considered pathogenic before the 1980s and because pre-1983 culture methods were less sensitive than PCR.
- The paper states it is unclear whether increased viral load during bacterial co-infection reflects bacterial–viral cooperation or simply bacterial burden on the host immune system, requiring further research.
- Evident from the text: as a narrative review, it does not report a systematic search strategy, inclusion/exclusion criteria, or formal quality assessment, and many cited estimates come from heterogeneous historical, autopsy, animal, and clinical studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 258 cited sources checked · 0 supported · 0 flagged
- Premisecitation
Bacterial co/secondary infection increases the morbidity and mortality of influenza and other viral respiratory infections.
“Bacterial co/secondary infection further increases morbidity and mortality of influenza infection, with Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus reported as the most common causes.”
- Also stated in: § Introduction · boosted
“bacterial co/secondary infection is known lead to increased morbidity (Smith and McCullers, 2014).”
- Also stated in: § Bacterial Co-Infection and Secondary Infections · boosted
“Laboratory, clinical and epidemiological research has made it abundantly clear that bacterial co/secondary infection can significantly increase the morbidity and mortality of viral infections (Gupta et al., 2008).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Smith and McCullers, 2014
Not checked in the free run.
- cites Gupta et al., 2008 source
Not checked in the free run.
- Also stated in: § Introduction · boosted
- Premisecitation
A range of bacteria including Legionella pneumophila, Streptococcus pyogenes, Neisseria meningitidis, Moraxella catarrhalis, S. pneumoniae, H. influenzae, S. aureus, Pseudomonas aeruginosa, and other Streptococcus and Staphylococcus spp. have been associated with co-infection of influenza.
“Legionella pneumophila (Rizzo et al., 2010), Streptococcus pyogenes (Chertow and Memoli, 2013), Neisseria meningitidis, Moraxella catarrhalis, S. pneumoniae, H. influenzae, S. aureus (Dela Cruz and Wunderink, 2017), Pseudomonas aeruginosa as well as a number of other Streptococcus and Staphylococcus spp. (Yang et al., 2016a) have all been associated with co-infection of influenza.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Rizzo et al., 2010 source
Not checked in the free run.
- cites Chertow and Memoli, 2013
Not checked in the free run.
- cites Dela Cruz and Wunderink, 2017
Not checked in the free run.
- Premisecitation
Influenza infection facilitates the acquisition, colonization, and development of disease from S. pneumoniae in people of all ages.
“Many studies have shown that influenza infection facilitates the acquisition, colonization and development of disease from S. pneumoniae in people of all ages (Shrestha et al., 2013; Grijalva et al., 2014; Siegel et al., 2014).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Co-infection may assist in the spreading of S. pneumoniae infection to the lower respiratory tract.
“These findings are reflected in several other studies, with some even showing that co-infection may assist in the spreading of S. pneumoniae infection to the lower respiratory tract (Takase et al., 1999; Seki et al., 2004).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Viral respiratory infections including influenza, respiratory syncytial virus, parainfluenza virus, and human metapneumovirus can be complicated by co/secondary bacterial infection by a variety of bacteria including S. pneumoniae, H. influenzae, and S. aureus.
“A number of viral infections (including infection from influenza virus, respiratory syncytial virus, parainfluenza virus and human metapneumovirus) can be complicated by co/secondary infection by a variety of bacteria including Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Smith and McCullers, 2014
Not checked in the free run.
- Premisecitation
Up to 75% of influenza-infected patients who develop pneumonia have confirmed bacterial co-infection.
“Up to 75% of those infected with influenza that go on to acquire pneumonia, are confirmed to have bacterial co-infection (Zambon, 2001).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zambon, 2001 source
Not checked in the free run.
- Premisenone given
S. pneumoniae, H. influenzae, and S. aureus are the most commonly reported bacteria associated with co/secondary infections during influenza pandemics since the late 1800s.
“with Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus reported as the most common causes.”
- Also stated in: § Pathobionts Associated with CO/Secondary Bacterial Infection · plain
“However, S. pneumoniae, H. influenzae, and S. aureus are the most commonly reported bacteria associated with co/secondary infections during influenza pandemics since the late 1800’s.”
Quote in the paperSubstantial claim - Also stated in: § Pathobionts Associated with CO/Secondary Bacterial Infection · plain
- Premisecitation
Mouse models provide evidence that influenza infection enhances secondary S. pneumoniae pneumonia.
“Mouse models support the concept that influenza facilitates the development of disease from S. pneumoniae; they have provided evidence that influenza infection enhances secondary S. pneumoniae pneumonia (McCullers and Rehg, 2002; McCullers and Bartmess, 2003).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites McCullers and Rehg, 2002
Not checked in the free run.
- cites McCullers and Bartmess, 2003
Not checked in the free run.
- Premisecitation
During the 2009 Swine influenza pandemic, secondary bacterial pneumonia was identified in 29-55% of mortalities.
“During the 2009 Swine influenza pandemic, there was an increase in hospital pneumonia cases as a result of secondary bacterial pneumonia, which was identified in 29–55% of mortalities (Centers for Disease Control and Prevention, 2009; Gill et al., 2010; Weinberger et al., 2012).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationreasoning
Lower vaccine implementation in low and middle income countries, fractional serotype coverage, and increasing antibiotic resistance mean influenza pandemic-associated S. pneumoniae secondary infection remains a significant risk to global health.
“lower levels of vaccine implementation in low and middle income countries coupled with fractional serotype coverage and increasing levels of antibiotic resistance, means the specter of influenza pandemic associated S. pneumoniae secondary infection remains a significant risk to global health.”
Quote in the paperSubstantial claim- Rests on an assumption: Antibiotic resistance is increasing.
- Rests on an assumption: Vaccine implementation is lower in low and middle income countries.
- Rests on an assumption: Pneumococcal vaccines have fractional serotype coverage.
- Interpretationcitation
Co-infection with influenza and H. influenzae results in more severe morbidity and poorer clinical outcome than infection with influenza or H. influenzae alone.
“It is now commonly accepted that co-infection results in more severe morbidity and poorer clinical outcome than infection of influenza or H. influenzae alone.”
Quote in the paperSubstantial claim - Premisecitation
H. influenzae has been associated with complication of disease during influenza pandemics.
“and has been associated with the complication of disease during influenza pandemics (Abrahams et al., 1919; Spooner et al., 1919; Brundage, 2006; Palacios et al., 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
More virulent pneumococcal serotypes caused a greater burden of disease in both co-infected mice and mice infected with S. pneumoniae alone.
“More virulent pneumococcal serotypes caused a greater burden of disease in both the co-infected mice and those infected with S. pneumoniae alone.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sharma-Chawla et al., 2016 source
Not checked in the free run.
- Premisecitation
High lethality is exhibited when H. influenzae and influenza are introduced 3 or 4 days apart.
“however, high lethality is exhibited when H. influenzae and influenza are introduced 3 or 4 days apart (Lee L.N. et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee L.N. et al., 2010
Not checked in the free run.
- Premisecitation
In a vaccine efficacy study, among individuals with influenza, vaccination against S. pneumoniae reduced pneumonia incidence by 45%.
“During a vaccine efficacy study, the incidence of pneumonia in those with influenza reduced by 45% in groups vaccinated against S. pneumoniae (Madhi et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Madhi et al., 2007 source
Not checked in the free run.
- Premisecitation
Pneumococcal vaccination reduces the risk of secondary bacterial pneumonia.
“Pneumococcal vaccination has shown to ameliorate the risk of secondary bacterial pneumonia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Madhi et al., 2007 source
Not checked in the free run.
- Premisecitation
Influenza and H. influenzae co-infection produces more epithelial cell destruction than single infection with either pathogen.
“More recently, Lee E.H. et al. (2010) undertook a similar study which provided comparable results and evidence that influenza and H. influenzae co-infection produces more epithelial cell destruction than single infection with either pathogen (Lee L.N. et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee L.N. et al., 2010
Not checked in the free run.
- Premisecitation
When influenza virus and H. influenzae are introduced at the same time, there is no synergistic relationship.
“Studies have shown that when influenza virus and H. influenzae are introduced at the same time there is no synergistic relationship.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee L.N. et al., 2010
Not checked in the free run.
- Premisecitation
When H. influenzae is introduced 7 or more days after influenza, there is no synergistic relationship.
“When H. influenzae is introduced 7 or more days after influenza there is again no synergistic relationship;”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee L.N. et al., 2010
Not checked in the free run.
- Premisecitation
In a mouse model, more cases of pneumonia and bacteraemia were observed in mice infected with both influenza A and S. pneumoniae than in mice infected with these pathogens individually, for all S. pneumoniae serotypes tested.
“More cases of pneumonia and bacteraemia were observed in mice infected with both influenza A and S. pneumoniae than in mice infected with these pathogens individually. This was the case for all S. pneumoniae serotypes tested.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sharma-Chawla et al., 2016 source
Not checked in the free run.
- Premisecitation
Individual infection with influenza or H. influenzae caused mild bronchiolitis within 4 days, from which the host lung recovered.
“individual infection caused mild bronchiolitis within 4 days of initial infection, from which the host lung was able to recover.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee L.N. et al., 2010
Not checked in the free run.
- Premisecitation
H. influenzae is commonly found to co/secondarily infect viral infection.
“Haemophilus influenzae is another bacteria commonly found to co/secondarily infect viral infection”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Mortality from H. influenzae and influenza co-infection is highly dependent on timing of introduction of the secondary microbe and density of bacterial colonization.
“mortality from H. influenzae and influenza co-infection is highly dependent on the timing of the introduction of the secondary microbe as well as density of bacterial colonization.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee L.N. et al., 2010
Not checked in the free run.
- Premisecitation
Influenza infection increases adherence of S. aureus, H. influenzae and S. pneumoniae to host pharyngeal cells.
“Influenza infection has been shown to increase the adherence of S. aureus (as well as H. influenzae and S. pneumoniae) to host pharyngeal cells (Fainstein et al., 1980).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fainstein et al., 1980 source
Not checked in the free run.
- Premisecitation
Community-acquired MRSA causes necrotising pneumonia with a 30% mortality rate.
“specifically necrotising pneumonia that is caused by community acquired Methicillin-resistant Staphylococcus aureus (MRSA) and has a 30% mortality rate (Murray et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Murray et al., 2010 source
Not checked in the free run.
- Premisecitation
S. aureus proteases that do not cleave influenza HA indirectly enhance morbidity by causing host inflammatory responses that produce host enzymes capable of cleaving HA.
“although not all strains of S. aureus produce proteases that cleave influenza HA, the proteases they do produce indirectly enhance morbidity by causing host inflammatory responses which result in the production of host enzymes that are capable of cleaving HA (Tashiro et al., 1987).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tashiro et al., 1987 source
Not checked in the free run.
- Interpretationcitation
Co-infection with S. aureus is lethal in mice that survive low influenza infection alone.
“The fact that the mice survived low influenza infection on its own, but could not survive co-infection with S. aureus shows the lethality of such co/secondary bacterial infection (Lee M.H. et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee M.H. et al., 2010
Not checked in the free run.
- Premisecitation
All mice infected with a high dose of influenza followed by a high dose of S. aureus died within 2 days of bacterial exposure.
“however, all mice infected with a high dose of influenza and then a high dose S. aureus died within 2 days of bacterial exposure, showing how death can be accelerated by co-infection.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee M.H. et al., 2010
Not checked in the free run.
- Interpretationreasoning
S. aureus protease cleavage of influenza HA contributes to increased severity of disease caused by co-infection versus individual influenza infection.
“This aspect contributes to the increased severity of disease caused by co-infection verses individual influenza infection.”
Quote in the paperSubstantial claim - Premisecitation
Mice infected with a low dose of influenza followed by a high dose of S. aureus died at 7 days.
“When mice were infected with a low dose of influenza and then a high dose S. aureus they died at 7 days.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee M.H. et al., 2010
Not checked in the free run.
- Premisecitation
In mouse models, pre-infection with influenza before S. aureus exposure increases morbidity and mortality compared with S. aureus exposure alone.
“mouse models have highlighted increased morbidity and mortality in mice that are pre-infected with influenza before they are exposed to S. aureus vs. those just exposed to S. aureus.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites DeLeo and Musser, 2010
Not checked in the free run.
- cites Lee M.H. et al., 2010
Not checked in the free run.
- cites Iverson et al., 2011 source
Not checked in the free run.
- Premisecitation
S. aureus has been found to complicate influenza infection, increasingly so in more recent years/pandemics.
“Staphylococcus aureus is a Gram-positive cocci that has been found to complicate influenza infection; increasingly so in more recent years/pandemics (Hers et al., 1958; Palacios et al., 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Several strains of S. aureus produce proteases that cleave influenza HA, increasing vRNP entry into host cells and overall progeny virions.
“Several strains of S. aureus produce proteases that cleaves influenza HA; the more protease that is available, the more HA can be cleaved meaning more vRNP can get into host cells meaning overall more progeny virions (Tashiro et al., 1987; Steinhauer, 1999; Samji, 2009).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Mice infected with high doses of influenza died within 4-7 days.
“Those infected with high doses of influenza died within 4–7 days;”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lee M.H. et al., 2010
Not checked in the free run.
- Premisecitation
Necrotising pneumonia is highly associated with either the presence of PVL or prior/co influenza infection.
“Necrotising pneumonia is highly associated with either the presence of Panton-Valentine leukocidin (PVL) or prior/co influenza infection (DeLeo and Musser, 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites DeLeo and Musser, 2010
Not checked in the free run.
- Premisecitation
Pneumonia as a consequence of bacterial infection occurred in up to 95% of deaths during the 1918 pandemic.
“pneumonia as a consequence of bacterial infection is estimated to have occurred in up to 95% of deaths during this pandemic (Morens et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Morens et al., 2008 source
Not checked in the free run.
- Premisecitation
Overall 95% of 1918 pandemic deaths were due to co/secondary bacterial pneumonia.
“Overall 95% of deaths were due to co/secondary bacterial pneumonia (Opie et al., 1921; Morens et al., 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Opie et al., 1921
Not checked in the free run.
- cites Morens et al., 2008 source
Not checked in the free run.
- Premisecitation
At Camp Logan, post-mortems found S. pneumoniae in the lungs of 44% and heart blood of 33%.
“Post-mortems found S. pneumoniae in the lungs of 44% and heart blood of 33% (Hall et al., 1918; Brundage, 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
A majority of 1918 pandemic deaths were due to secondary S. pneumoniae infection.
“A majority of those deaths due to secondary S. pneumoniae infection (Brundage and Shanks, 2008; Morens et al., 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
At Camp Devens, out of 37 autopsies, 43% were positive for pure growth of H. influenzae in at least one lobe of the lung.
“Out of 37 autopsies performed, 43% were positive for pure growth of H. influenzae in at least one lobe of the lung.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
At Camp Devens in 1918, a quarter of all troops were diagnosed with influenza within a 1-month period.
“Within a 1-month period in 1918 at the military Camp Devens, a quarter of all troops were diagnosed with influenza.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
At least 90% of lung tissue samples from 1918 pandemic post-mortems showed evidence of bacterial infection.
“Additional post-mortems of lung tissue suggest that at least 90% of samples showed evidence of bacterial infection (Oxford et al., 2002; Morens et al., 2008; Chien et al., 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Influenza with secondary bacterial infection of S. pneumoniae, H. influenzae and/or Staphylococcus sp. was associated with major outbreaks of purulent bronchitis in 1916 and 1917.
“Influenza with secondary bacterial infection of S. pneumoniae (and other Streptococcus sp.), H. influenzae and/or Staphylococcus sp. was associated with major outbreaks of purulent bronchitis in 1916 and 1917 (Brundage, 2006; Joseph et al., 2013).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Post-mortem cultures show evidence of bacterial infection in up to 80% of all severe and fatal cases during the 1957 pandemic.
“Post-mortem cultures show evidence of bacterial infection in up to 80% of all severe and fatal cases (Hers et al., 1958; Morens et al., 2008; Gill et al., 2010).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
During the 2009 pandemic, predominantly children and young adults were affected, particularly those aged 12-22.
“Unlike other pandemics and yearly epidemics, during this pandemic it was predominantly children and young adults that were affected, particularly those aged 12–22 (Gill et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gill et al., 2010 source
Not checked in the free run.
- Premisecitation
Although not the most common bacterium found, S. pneumoniae was the most strongly associated with severe disease in the Argentina study.
“Although not the most common bacteria found, S. pneumoniae was the most strongly associated with severe disease (Palacios et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Palacios et al., 2009 source
Not checked in the free run.
- Interpretationreasoning
During the 1968-1969 Hong Kong and 1957 Asian influenza pandemics, S. aureus clearly had a larger impact than S. pneumoniae.
“In previous pandemics S. pneumoniae has been proposed as the major contributor of mortality and morbidity, however, during this 1968–1969 Hong Kong and the 1957 Asian influenza pandemic S. aureus clearly had a larger impact.”
Quote in the paperSubstantial claim - Premisecitation
The severity of co/secondary infection depends on multiple factors such as the strain of virus and serotype/strain of bacteria, the lag between viral infection and bacterial exposure, and density of bacterial colonization.
“The severity of co/secondary infection depends on multiple factors such as the strain of virus and serotype/strain of bacteria, the lag between viral infection and bacterial exposure and density of bacterial colonization (Lee L.N. et al., 2010; McCullers et al., 2010; Smith and McCullers, 2014).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Lee L.N. et al., 2010
Not checked in the free run.
- cites McCullers et al., 2010 source
Not checked in the free run.
- cites Smith and McCullers, 2014
Not checked in the free run.
- Premisecitation
In mice infected with influenza, colonization and adherence of S. pneumoniae to tracheal cells is enhanced.
“Plotkowski et al. (1986) found enhanced colonization and adherence of S. pneumoniae to the tracheal cells of mice when they were infected with influenza (Plotkowski et al., 1986).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Plotkowski et al., 1986 source
Not checked in the free run.
- Premisecitation
In adult subjects inoculated with influenza, after 6 days 15% were heavily colonized by S. pneumoniae.
“After 6 days 15% of the subjects were heavily colonized by S. pneumoniae (Wadowsky et al., 1995).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wadowsky et al., 1995 source
Not checked in the free run.
- Premisecitation
Influenza vaccination can reduce the occurrence of bacterial pneumonia.
“Studies have shown that influenza vaccination can reduce the occurrence of bacterial pneumonia (Fedson et al., 1993; Nichol et al., 1998).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
In ferrets intranasally inoculated with influenza, prior viral infection increases colonization and adherence of S. aureus.
“Other studies have intranasally inoculated ferrets with influenza, finding prior viral infection increases colonization and adherence of S. aureus (Sanford and Ramsay, 1987).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sanford and Ramsay, 1987
Not checked in the free run.
- Premisecitation
Influenza B has also been associated with severe bacterial co/secondary infection, although reported less.
“Although reported less, influenza B has also been associated with severe bacterial co/secondary infection (Finelli et al., 2008; Aebi et al., 2010).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
M. catarrhalis has been highlighted as a frequent source of co-infection for influenza since the early 1980s.
“M. catarrhalis has been highlighted as a frequent source of co-infection for influenza since the early 1980’s (Klein et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Klein et al., 2016 source
Not checked in the free run.
- Premisecitation
Some HA types (types 5 and 7) can acquire insertional mutations at the cleavage site, broadening protease specificity.
“some HA types (i.e., types 5 and 7) have the ability to acquire insertional mutations at the cleavage site which changes their recognition site in such a way that specificity is broadened so more proteases are recognized (Kash and Taubenberger, 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kash and Taubenberger, 2015
Not checked in the free run.
- Premisecitation
In animal models, influenza infection increases and prolongs bacterial growth due to reduced macrophage accumulation and decreased bacterial clearance from reduced phagocytic activity.
“Many studies involving animal models have shown that influenza infection increases and prolongs bacterial growth, due to reduced macrophage accumulation and decreased bacterial clearance due to reduced phagocytic activity (Kleinerman et al., 1976; Wyde et al., 1989; Sun and Metzger, 2008).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
PB1-F2 helps reduce bacterial clearance, increasing occurrence and severity of co/secondary bacterial infection, by causing cell death in host monocytes.
“It also helps reduce bacterial clearance, increasing the occurrence and severity of co/secondary bacterial infection, by causing cell death in host monocytes (Conenello and Palese, 2007; Iverson et al., 2011).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Conenello and Palese, 2007
Not checked in the free run.
- cites Iverson et al., 2011 source
Not checked in the free run.
- Premisecitation
In response to viral infection, host inflammatory responses may up-regulate expression of host receptor molecules and other molecules that bacteria can use as receptors.
“In response to viral infection, host inflammatory responses may cause an up-regulation in the expression of host receptor molecules and other molecules that bacteria can use as a receptors (Hakansson et al., 1994; Peltola and McCullers, 2004).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Hakansson et al., 1994 source
Not checked in the free run.
- cites Peltola and McCullers, 2004
Not checked in the free run.
- Premisecitation
Viral-induced immunosuppression can allow bacterial superinfection.
“Viral induced immunosuppression can allow for a bacterial super infection”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Peltola and McCullers, 2004
Not checked in the free run.
- cites Brundage, 2006 source
Not checked in the free run.
- cites Wu et al., 2011
Not checked in the free run.
- Premisecitation
Influenza neuraminidase increases adhesion of some bacterial species by removing sialic acid to expose host cell receptors.
“Influenza produces NA, which increases adhesion of some bacterial species by removing sialic acid to expose host cell receptors (McCullers and Bartmess, 2003; Peltola and McCullers, 2004).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites McCullers and Bartmess, 2003
Not checked in the free run.
- cites Peltola and McCullers, 2004
Not checked in the free run.
- Premisecitation
Some bacteria, such as group B Streptococci, contain sialic acid, which allows direct binding to viral hemagglutinin expressed by influenza-infected host cells.
“Alternatively some bacteria, i.e., group B Streptococci, contain sialic acid which allows for direct binding to the viral HA expressed by influenza infected host cells (Okamoto et al., 2003; Peltola and McCullers, 2004).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Okamoto et al., 2003 source
Not checked in the free run.
- cites Peltola and McCullers, 2004
Not checked in the free run.
- Premisecitation
To be effective, NA must be complementary and share the same receptor specificity as HA.
“To be truly effective the NA must be complementary and share the same receptor specificity as HA, so if the viral HA binds to α2-3 sialic acid then the NA should hydrolyse α2-3 sialic acid (Baum and Paulson, 1991).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Baum and Paulson, 1991
Not checked in the free run.
- Interpretationcitation
The resulting suppression of phagocytosis paves the way for successful bacterial infection.
“The resulting suppression of phagocytosis paves the way for successful bacterial infection (Sun and Metzger, 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sun and Metzger, 2008 source
Not checked in the free run.
- Premisecitation
Even after influenza is cleared, S. pneumoniae bacterial clearance is affected.
“Even after influenza is cleared, S. pneumoniae bacterial clearance is affected.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sharma-Chawla et al., 2016 source
Not checked in the free run.
- Premisecitation
Exposure of apical receptors like integrins permits adhesion of bacteria such as S. aureus and P. aeruginosa.
“For example the exposure of apical receptors like integrins permit the adhesion of bacteria such as S. aureus and P. aeruginosa (Sanford et al., 1978; Davison and Sanford, 1981; Bucior et al., 2012; Smith and McCullers, 2014).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
The Sharma-Chawla et al. study highlighted serotype-dependent differences in S. pneumoniae co-infection.
“This study has highlighted some serotype dependent differences”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sharma-Chawla et al., 2016 source
Not checked in the free run.
- Premisecitation
Following bacterial colonization, disease develops due to specific characteristics of viral infection that facilitate bacterial adhesion and penetration.
“Following bacterial colonization, disease develops due to specific characteristics of viral infection that facilitate bacterial adhesion and penetration (Selinger et al., 1981).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Selinger et al., 1981 source
Not checked in the free run.
- Premisecitation
During T cell responses to viral infection, IFNγ inhibits bacterial clearance from the respiratory system by macrophages.
“during T cell responses to viral infection they have been shown to inhibit bacterial clearance from the respiratory system by macrophages.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sun and Metzger, 2008 source
Not checked in the free run.
- Premisecitation
S. pneumoniae and influenza co-infection results in a reduction in local alveolar macrophages due to increased death of these macrophages by apoptosis and necrosis.
“Additionally it has recently been shown that S. pneumoniae and influenza co-infection results in a reduction in the number of local alveolar macrophages, this due to increased death of these macrophages by apoptosis and necrosis (Sharma-Chawla et al., 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sharma-Chawla et al., 2016 source
Not checked in the free run.
- Premisereasoning
Damaged host cells, whether damaged directly by virus or by inflammation and immune cell responses, provide additional adhesion sites allowing increased bacterial adhesion.
“Damaged host cells, whether damaged directly by the virus or by inflammation and immune cell responses, provide additional adhesion sites allowing for increased bacterial adhesion.”
Quote in the paperSubstantial claim - Premisecitation
Type I IFNs inhibit IL-23-dependent induction of Th17 immunity.
“Additionally, Type I IFNs inhibit interleukin 23 (IL-23) dependent induction of T helper cell 17 (Th17) immunity”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisereasoning
IFNγ, by assisting induction of specific anti-influenza adaptive immunity, downregulates innate immunity.
“It is thought that as they assist in the induction of specific anti-influenza adaptive immunity they down regulate innate immunity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sun and Metzger, 2008 source
Not checked in the free run.
- Premisecitation
IFNγ increases macrophage activation during innate immunity.
“They increase macrophage activation during innate immunity (Scott et al., 2004)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scott et al., 2004 source
Not checked in the free run.
- Premisecitation
Influenza infection results in the production of IFN.
“Influenza infection is known to result in the production of IFN”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Schoenborn and Wilson, 2007
Not checked in the free run.
- Premisecitation
A number of studies have documented an increase in viral load as viral clearance is reduced during bacterial co-infection.
“A number of studies have documented an increase in viral load as viral clearance is reduced during bacterial co-infection.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Peltola and McCullers, 2004
Not checked in the free run.
- cites Iverson et al., 2011 source
Not checked in the free run.
- cites Smith and McCullers, 2014
Not checked in the free run.
- Premisecitation
Viral and bacterial co-infection of monocyte-derived macrophages synergistically induces a pro-inflammatory response related to type-I IFN and JAK-STAT signaling pathways.
“Viral and bacterial co-infection of monocyte derived macrophages synergistically induces a pro-inflammatory response related to the type-I IFN and JAK-STAT signaling pathways (Hoffmann et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hoffmann et al., 2016 source
Not checked in the free run.
- Premisecitation
Co-infection results in a synergistic increase in type II IFN (IFNγ) compared to individual infection of influenza or S. pneumoniae.
“Co-infection also results in a synergistic increase in type II IFN (IFNγ) when compared to individual infection of influenza or S. pneumoniae”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hoffmann et al., 2016 source
Not checked in the free run.
- Premisecitation
Influenza positively affects colonization of S. aureus by causing increased type III IFN expression, which alters IL-22 responses and impairs host expression of antimicrobial peptides.
“In addition to this, influenza positively affects the colonization of S. aureus by causing increased type III- IFN expression, which alters the IL-22 responses impairing host expression of antimicrobial peptides (Mulcahy and McLoughlin, 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mulcahy and McLoughlin, 2016
Not checked in the free run.
- Interpretationreasoning
Bacterial infection is able to worsen clinical outcome and severity of disease.
“Bacterial infection is then able to worsen clinical outcome and the severity of disease.”
Quote in the paperSubstantial claim - Premisecitation
Patients suffering severe pneumonia show significantly higher levels of IP-10 than those with minor cases of pneumonia.
“Patients suffering severe pneumonia show significantly higher levels of IP-10 than those with minor cases of pneumonia.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hoffmann et al., 2016 source
Not checked in the free run.
- Premisecitation
IL-17 is important in clearance of S. aureus by neutrophils.
“IL-17 is important in the clearance of S. aureus by neutrophils (Archer et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Archer et al., 2013 source
Not checked in the free run.
- Premisecitation
During co/secondary S. pneumoniae infection, type I IFNs inhibit production of KC/CXCL1 and Mip2/CXCL2, resulting in attenuated neutrophil response.
“During co/secondary S. pneumoniae infection, type I IFNs have been shown to inhibit the production of specific chemokines (KC/CXCL1 and Mip2/CXCL2) resulting in an attenuated neutrophil response (Shahangian et al., 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shahangian et al., 2009 source
Not checked in the free run.
- Premisecitation
Capsule switching helps S. pneumoniae evade immunity.
“such as capsule switching which help S. pneumoniae evade immunity (Pai et al., 2005a,b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pai et al., 2005a,b
Not checked in the free run.
- Premisecitation
Influenza A infection significantly decreases IL-1β production.
“Robinson et al. (2013) have also shown that influenza A infection significantly decreased IL-1β production”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Robinson et al., 2013 source
Not checked in the free run.
- Premisecitation
CXCL10 (IP-10) is secreted in response to IFNγ.
“CXCL10 (aka IFNγ-induced protein 10/IP-10) is secreted in response.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Influenza and S. pneumoniae infections can lead to synergistic and non-synergistic dysregulation of cytokine responses.
“Influenza and S. pneumoniae infections can also lead to synergistic and non-synergistic dysregulation of cytokine responses (Wu et al., 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wu et al., 2011
Not checked in the free run.
- Interpretationreasoning
Viral and bacterial co-infection can be mutually beneficial, further helping viral infection.
“Of course viral and bacterial co-infection can be mutually beneficial, further helping viral infection, which is bad news for public health.”
Quote in the paperSubstantial claim - Premisereasoning
Influenza infection results in a reduction in the production of IL-17 and IL-22.
“As previously described influenza infection results in a reduction in the production of IL-17 and 22.”
Quote in the paperSubstantial claim
- May combine two claims. 82
- Classified as probably not a substantial claim. 20
May combine two claims.
PremisecitationIn squirrel monkeys, co-infection with influenza A and S. pneumoniae resulted in severe morbidity with a 75% death rate within 40 hours, whereas individual infections caused minor illness with 100% survival.
“Co-infection of influenza A with S. pneumoniae resulted in severe morbidity with a 75% death rate within 40 h, clear evidence of the consequences of co/secondary bacterial infection (Berendt et al., 1975).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Berendt et al., 1975 source
Not checked in the free run.
May combine two claims.
PremisecitationCo-infection of a virus and a bacterium can occur either from mixed viral-bacterial infection or from a viral infection sequentially followed by a bacterial infection; sequential bacterial infection normally occurs within 7 days of the viral infection.
“Wu et al. (2011), showed that co-infection of a virus and a bacterium can either occur from mixed viral bacterial infection, or from a viral infection being sequentially followed by a bacterial infection. Sequential bacterial infection normally occurs within a 7-day period of the viral infection.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wu et al., 2011
Not checked in the free run.
May combine two claims.
PremisecitationIn laboratory-confirmed influenza, bacterial co/secondary infection has been reported in up to 65% of cases, although a meta-analysis found that in most included studies the figure ranged between 11 and 35%.
“Studies have shown that up to 65% of laboratory confirmed cases of influenza infection exhibited bacterial co/secondary infection, although Klein et al. (2016) state that in the majority of the research included in their meta-analysis this figure ranged between 11 and 35%.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Klein et al., 2016 source
Not checked in the free run.
May combine two claims.
PremisecitationS. pneumoniae is the most common bacterium found in viral secondary bacterial infections and is particularly associated with high mortality and morbidity during influenza epidemics and pandemics.
“Streptococcus pneumoniae is the most common bacteria found in viral secondary bacterial infections, and is particularly associated with causing high mortality and morbidity during influenza epidemics and pandemics (Brundage, 2006; Joseph et al., 2013).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationInfluenza neuraminidase releases sialic acid from host cells and mucus, which S. pneumoniae can catabolise; influenza also increases mucus production, further increasing the metabolite available for S. pneumoniae.
“This is partly due to S. pneumoniae’s ability to catabolise sialic acid which is released from host cells and mucus by influenza’s NA. Influenza infection also results in increased mucus production, further increasing the amount of metabolite available for S. pneumoniae.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Siegel et al., 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationImmunosuppression is associated with more severe morbidity and a higher risk of mortality from co/secondary bacterial infection.
“Immunosuppression is associated with more severe morbidity and a much higher risk of mortality from co/secondary bacterial infection (Rice et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rice et al., 2012 source
Not checked in the free run.
May combine two claims.
PremisecitationInfection with some influenza subtypes, such as H1N1 and H5N1, typically results in lymphopenia, which has been associated with higher viral load.
“Furthermore infection with some influenza subtypes, for instance H1N1 and H5N1, typically result in lymphopenia, a state of abnormally low levels of lymphocytes, which has been associated with higher viral load.”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationH. influenzae serotype B was a major cause of invasive disease.
“H. influenzae serotype B was a major cause of invasive disease (Wenger, 1998; Murphy, 2003; Chin et al., 2005; Brouwer et al., 2010)”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationWhere lymphopenia occurs, studies have shown a corresponding increase in macrophages, supported by increases in IP-10, IL-8, IL-6, and MCP-1.
“Where lymphopenia occurs, studies have shown a corresponding increase in macrophages.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationIn a mouse model, highly invasive pneumococcal serotype 4 caused pneumonia in 58% and bacteraemia in 21% in single infection; co-infection with influenza increased these to 100% and 90%, respectively, and mortality increased from 0% to 79%.
“The highly invasive pneumococcal serotype 4 caused pneumonia in 58% of mice and bacteraemia in 21% in a single infection model. When co-infecting with influenza these figures increased to 100 and 90% for pneumonia and bacteraemia, respectively. Mortality rates increased from 0% for individual infection to 79% during co-infection.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sharma-Chawla et al., 2016 source
Not checked in the free run.
May combine two claims.
PremisecitationStudies have shown a 90% reduction of alveolar macrophages in mice within a week of influenza infection, with evidence of necrosis in the remaining macrophages.
“Studies have shown a 90% reduction of alveolar macrophages in mice within a week of influenza infection, and evidence of necrosis in the remaining macrophages (Robinson et al., 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Robinson et al., 2015 source
Not checked in the free run.
May combine two claims.
PremisecitationCo-infection with influenza and H. influenzae caused bronchial necrosis, bronchial inflammation and bronchitis within the same time period or less, and led to epithelial erosion.
“Conversely, co-infection caused bronchial necrosis, bronchial inflammation and bronchitis within the same time period or less, and led to further complication such as epithelial erosion (Lee L.N. et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee L.N. et al., 2010
Not checked in the free run.
May combine two claims.
PremisecitationIn Shope's study, co-infection with influenza and H. influenzae resulted in severe disease or death, whereas individual infections caused only mild infection or disease.
“Shope found that co-infection resulted in severe disease or death when on their own H. influenzae and influenza only caused mild infection or disease (Shope, 1931).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shope, 1931 source
Not checked in the free run.
May combine two claims.
PremisecitationIn rats, prior influenza infection reduced the dose of H. influenzae required to cause meningitis by 100-fold, while about 50% acquired meningitis in both groups.
“In both groups ∼50% of the rats acquired meningitis, however, the naïve rats required a 100-fold larger dose of H. influenzae (Michaels et al., 1977).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Michaels et al., 1977 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationWidespread implementation of the Hib vaccine has significantly reduced the burden of H. influenzae serotype B disease.
“although widespread implementation of the Hib vaccine has significantly reduced the burden of disease (Rosenstein and Perkins, 2000).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rosenstein and Perkins, 2000
Not checked in the free run.
May combine two claims.
PremisecitationIn a mouse model, carrier strain serotype 19F caused pneumonia in 91% and bacteraemia in 0% in single infection; co-infection with influenza increased these to 100% and 33%, and mortality rose from 0% to 63%.
“In comparison, individual infection with a carrier strain (of lower invasive potential) of serotype 19F, caused pneumonia in 91% of cases and bacteraemia in 0%. When co-infecting with influenza and 19F these figures increased to 100 and 33%. Mortality rose from 0% during individual infection to 63% during co-infection (Sharma-Chawla et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sharma-Chawla et al., 2016 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNon-typeable H. influenzae remains a significant cause of bacterial meningitis, otitis media and exacerbations of chronic lung disease such as COPD worldwide.
“Those H. influenzae that lack a capsule, denoted non-typeable H. influenzae (NTHi), remain a significant cause of bacterial meningitis, otitis media and exacerbations of chronic lung disease such as COPD worldwide (Langereis and de Jonge, 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Langereis and de Jonge, 2015
Not checked in the free run.
May combine two claims.
Premisecitationde Jong et al. (2006) found that influenza infection caused lower levels of cytotoxic T cell lymphocytes, which would negatively affect acquired immunity.
“de Jong et al. (2006) found influenza infection caused lower levels of cytotoxic T cell lymphocytes, which would therefore negatively affect acquired immunity (de Jong et al., 2006; Cunha et al., 2009).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationInfluenza infection causes decreased mucociliary activity, dysfunction of immune cells, and reduced phagocytosis, which reduces clearance of the virus from host airways and the host's ability to fight the virus.
“Virally induced decreased mucociliary activity, the dysfunction of immune cells and the reduction of phagocytosis reduces clearance of the virus from the host airways and the host’s ability to fight the virus (Brundage, 2006; Wu et al., 2011; Cauley and Vella, 2015).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Brundage, 2006 source
Not checked in the free run.
- cites Wu et al., 2011
Not checked in the free run.
- cites Cauley and Vella, 2015
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe 1918 influenza pandemic was caused by influenza strain A(H1N1).
“The 1918 influenza pandemic was a result of influenza strain A (H1N1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationS. aureus is transiently carried in the nose of 30% of the population, and 20% have persistent nasal colonization.
“S. aureus is transiently carried in the nose of 30% of the population, whilst 20% of the population have persistent nasal colonization (Wertheim et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wertheim et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationIn mice, low doses of influenza, low doses of S. aureus, and high doses of S. aureus were survivable.
“Lee M.H. et al. (2010) showed that mice infected with low doses of influenza, low doses of S. aureus and high doses of S. aureus were able to survive.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee M.H. et al., 2010
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIndia alone suffered 7 million deaths during the 1918 pandemic.
“India alone suffered 7 million deaths (Potter, 2001; Hilleman, 2002; Brundage, 2006; Michaelis et al., 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationThe main groups affected by the 1918 pandemic were those aged 20-40, infants, and those over 65.
“The main groups of individuals affected by this pandemic were those aged 20–40 years old, in addition to infants and those over 65.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Potter, 2001 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationS. aureus is an opportunistic pathogen and a major cause of bacteraemia.
“Like H. influenzae and S. pneumoniae, S. aureus is an opportunistic pathogen and a major cause of bacteraemia (Wertheim et al., 2005; Tong et al., 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe 1918 pandemic infected 50% of the world's population and resulted in approximately 40-50 million deaths worldwide.
“It is considered the most devastating influenza pandemic ever recorded, infecting 50% of the world’s population and resulting in approximately 40–50 million deaths worldwide.”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationIn mouse models, pre-infection with influenza before S. aureus exposure increases lung damage and bacterial density.
“Increased lung damage and bacterial density has also been shown (DeLeo and Musser, 2010; Lee M.H. et al., 2010; Iverson et al., 2011).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites DeLeo and Musser, 2010
Not checked in the free run.
- cites Lee M.H. et al., 2010
Not checked in the free run.
- cites Iverson et al., 2011 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationS. aureus is a common cause of pneumonia.
“It is also a common cause of pneumonia (Kollef et al., 2005);”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kollef et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationNasopharyngeal and sputum samples from 158 pneumonia cases at Camp Fremont found S. pneumoniae in 41%, H. influenzae in 38%, and other Streptococcus spp. in 29%.
“Nasopharyngeal and sputum samples from 158 pneumonia cases found S. pneumoniae in 41% of cases, H. influenzae in 38%, and other Streptococcus spp. in 29% (Brem et al., 1918).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brem et al., 1918 source
Not checked in the free run.
May combine two claims.
PremisecitationAt Camp Jackson, 17% of influenza cases progressed to pneumonia, and 31% of pneumonia cases were fatal.
“At Camp Jackson, 17% of influenza cases progressed to pneumonia with a further 31% of pneumonia cases proving fatal.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAt Camp Jackson, autopsies found S. pneumoniae to be the bacterial co-infection most associated with pneumonia, and 155 of 312 lung cultures were positive for S. aureus.
“Autopsies found S. pneumoniae to be the bacterial co-infection most associated with pneumonia, however, 155 of 312 lung cultures were positive for S. aureus (Michael, 1942; Brundage, 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationIn 1919 re-examination of lung tissue from 1918 fatalities, S. pyogenes longus was found in 36%, S. pneumoniae in 29%, and H. influenzae in 25%.
“Further lung tissue from fatalities of this pandemic were re-examined in 1919; S. pyogenes longus was found in 36% of cases, S. pneumoniae in 29% of cases and H. influenzae in 25% (Abrahams et al., 1919; Brundage, 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationCamp Fremont experienced 2418 hospitalizations, 17% had pneumonia, of which 36% were fatal.
“Camp Fremont experienced 2418 hospitalizations, 17% had pneumonia of which 36% were fatal.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brem et al., 1918 source
Not checked in the free run.
May combine two claims.
PremisecitationOut of 20 tested sputum specimens from a British army camp in north France, 90% presented with H. influenzae, 65% with S. pneumoniae, 25% with other Streptococcus spp., and 15% with Staphylococcus spp.
“Out of 20 tested sputum specimens from a British army camp based in north France, 90% presented with H. influenzae, 65% presented with S. pneumoniae, 25% with other Streptococcus spp. and 15% with Staphylococcus spp.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAt Camp Devens, of those infected with influenza, 17% developed pneumonia, of which 35% were fatal.
“Of those infected, 17% developed pneumonia, of which 35% of cases were fatal.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAt Camp Logan, 2,487 influenza-associated hospitalizations were recorded, 17% acquired pneumonia, and 4% of pneumonia cases were fatal.
“Here 2,487 influenza-associated hospitalizations were recorded, 17% acquired pneumonia with 4% of these cases being fatal.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAt Camp Custer, 21% of influenza cases progressed to pneumonia, of which 28% died.
“At Camp Custer, 21% of influenza cases progressed to pneumonia, of which 28% died.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Blanton and Irons, 1918
Not checked in the free run.
- cites Brundage, 2006 source
Not checked in the free run.
May combine two claims.
PremisecitationAt Camp Devens, blood culture revealed 65% had S. pneumoniae, 2.5% had H. influenzae, and 1.3% had S. aureus.
“Blood culture revealed 65% had S. pneumoniae, 2.5% had H. influenzae and 1.3% had S. aureus (Spooner et al., 1919; Brundage, 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAt Camp Custer, sputum cultures proved presence of S. pneumoniae in 26% of cases, and 28% of lung and blood cultures were positive for S. pneumoniae.
“Sputum cultures proved the presence of S. pneumoniae in 26% of cases. Further investigation found 28% of lung and blood cultures were positive for S. pneumoniae, again acting as supporting evidence of the invasive potential of such co-infections (Blanton and Irons, 1918; Brundage, 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Blanton and Irons, 1918
Not checked in the free run.
- cites Brundage, 2006 source
Not checked in the free run.
May combine two claims.
PremisecitationAmong specimens positive for H. influenzae, many exhibited simultaneous H. influenzae and S. pneumoniae co-infection, with H. influenzae identified as the primary bacterial infector.
“Out of the specimens positive for H. influenzae, many exhibited simultaneous H. influenzae and S. pneumoniae co-infection; with H. influenzae identified as the primary bacterial infector.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAt the Mayo Clinic in Minnesota, of 129 adults diagnosed with pandemic influenza, pneumonia was established in 16%, of which 40% (6% of all 129) were fatal.
“Of 129 adults diagnosed with pandemic influenza, pneumonia was established in 16%, of which 40% of these cases (6% of all 129 influenza cases) were fatal.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lindsay et al., 1970 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the United States, review of 77 deaths during May-August 2009 found bacterial co-infection in almost 30% of cases; 46% were with S. pneumoniae, 9% with S. aureus, and 1% with H. influenzae.
“Further studies in the United States have reviewed 77 deaths during the period of May–August 2009 and found bacterial co-infection in almost 30% of cases; 46% of which were with S. pneumoniae, 9% with S. aureus and 1% with H. influenzae (Centers for Disease Control and Prevention, 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Centers for Disease Control and Prevention, 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationWithin 4 weeks, the 2009 influenza A(H1N1) outbreak spread to 41 countries, resulting in 11,034 confirmed cases and 85 deaths.
“Within 4 weeks this outbreak of influenza A(H1N1) had spread to 41 countries resulting in 11,034 confirmed cases and 85 deaths (Michaelis et al., 2009; Wang and Palese, 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Michaelis et al., 2009 source
Not checked in the free run.
- cites Wang and Palese, 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOverall 33,800 people died in the United States during the 1968-1969 pandemic, and the pandemic cost 3.9 billion dollars.
“Overall 33,800 people died in the United States (Klimov et al., 1999) and the pandemic cost 3.9 billion dollars (Hilleman, 2002).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationOut of 79 cases of fatal influenza with pneumonia complications during the 1968-1969 pandemic, 16% had bacterial co-infection, with S. pneumoniae (6%), S. pyogenes (5%), and S. aureus (1%) as main causes; more than one bacterium was present in 4% of cases.
“out of 79 cases of fatal influenza with pneumonia complications, 16% had bacterial co-infection with S. pneumoniae (6%), S. pyogenes (5%), and S. aureus (1%) being the main causes. More than one of these bacteria were present in 4% of cases (Schwarzmann et al., 1971; Metersky et al., 2012).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationOf 148 fully examined deaths presumed to be from the 1957 Asian pandemic in the Netherlands, 75% presented with bacterial pneumonia, 15% were positive for S. pneumoniae, and 59% were positive for S. aureus.
“of the 148 deaths presumed to be from the Asian pandemic influenza strain that were examined fully, 75% presented with bacterial pneumonia of which 15% were positive for S. pneumoniae and 59% were positive for S. aureus (Hers et al., 1958).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hers et al., 1958 source
Not checked in the free run.
May combine two claims.
PremisecitationAt the Mayo Clinic, S. aureus or P. aeruginosa bacterial infection was present in 75% of all fatal cases, indicating bacterial co/secondary infection was a major determinant of severe disease and death.
“S. aureus or P. aeruginosa bacterial infection was present in 75% of all fatal cases, indicating bacterial co/secondary infection was a major determinant of severe disease and death (Lindsay et al., 1970).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lindsay et al., 1970 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Argentina, among almost 200 cases of pandemic influenza, H. influenzae was found in 52%, S. pneumoniae in 31%, and S. aureus in 18% of nasopharyngeal swab samples.
“Palacios et al. (2009) examined nasopharyngeal swab samples from almost 200 cases of pandemic influenza. H. influenzae was found in 52%, S. pneumoniae was found in 31% and S. aureus in 18% of samples.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Palacios et al., 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe 1957 Asian influenza pandemic affected 40-50% of people worldwide and was caused by influenza strain A(H2N2).
“This pandemic affected 40–50% of people worldwide. The cause was influenza strain A (H2N2) (Potter, 2001).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Potter, 2001 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe death toll in the United States during the 1957 pandemic was 69,800.
“the death toll in the United States is accurately reported to have been 69, 800 (Klimov et al., 1999; Hilleman, 2002).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThere is a positive association between colonization of H. influenzae and S. pneumoniae, and colonization is a prerequisite for disease.
“Of course it is known that there is a positive association between the colonization of H. influenzae and S. pneumoniae, and colonization is a prerequisite for disease, so the presence of such co-infection fits with current knowledge (Jacoby et al., 2007; Abdullahi et al., 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationBacteraemia was observed in 5% of admissions in the pediatric ICU study, for which S. aureus was the main cause.
“Bacteraemia was observed in 5% of admissions, for which S. aureus was the main cause (Randolph et al., 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Randolph et al., 2011 source
Not checked in the free run.
May combine two claims.
PremisecitationA hospital in Atlanta suffered a threefold increase in cases of Staphylococcal pneumonia during the 1968-1969 pandemic, and Staphylococcal infection caused 26% of pneumonia cases.
“A hospital in Atlanta suffered a threefold increase in cases of Staphylococcal pneumonia during this pandemic. Staphylococcal infection caused 26% of pneumonia cases during this period, and a high correlation was recognized between influenza infection and bacterial pneumonia (Schwarzmann et al., 1971).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schwarzmann et al., 1971 source
Not checked in the free run.
May combine two claims.
PremisecitationIn 1969, England and Wales saw a 55% increase in respiratory deaths, of which co/secondary bacterial infection was a major contributor.
“In 1969, England and Wales saw a 55% increase in respiratory deaths, of which co/secondary bacterial infection was shown to be a major contributor (Tillett et al., 1983).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tillett et al., 1983 source
Not checked in the free run.
May combine two claims.
PremisecitationDuring the 1957 pandemic, the United States and many other countries experienced an increase in hospitalization rates, with a majority due to pneumonia predominantly caused by S. pneumoniae, H. influenzae, and S. aureus.
“During this pandemic the United States, and many other countries, experienced an increase in hospitalization rates. A majority were due to pneumonia, predominantly caused by S. pneumoniae, H. influenzae, and S. aureus infection (Petersdorf et al., 1959).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Petersdorf et al., 1959 source
Not checked in the free run.
May combine two claims.
PremisecitationIn 838 critically ill children infected with pandemic influenza in US pediatric intensive care units, within 72 h of admission 33% exhibited bacterial co-infection; in 26% of these cases S. aureus was identified (48% MRSA), 5.5% were positive for S. pneumoniae, and 5% for H. influenzae.
“investigated 838 critically ill children who were infected with pandemic influenza. Within 72 h of admission to the intensive care unit 33% exhibited bacterial co-infection; in 26% of these cases S. aureus was identified as the cause (48% of which were MRSA), 5.5% were positive for S. pneumoniae and 5% were positive for H. influenzae.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Randolph et al., 2011 source
Not checked in the free run.
May combine two claims.
PremisecitationIn 140 people hospitalized with pneumonia at Sheffield City General Hospital in 1957, a majority showed evidence of influenza A infection; 27% had co/secondary S. aureus infection (47% death rate), 15% S. pneumoniae, and 4% H. influenzae.
“A majority showed evidence of influenza A infection; 27% of those had co/secondary infection of S. aureus (which had a 47% death rate), 15% S. pneumoniae and 4% H. influenzae, although this is likely to be an underestimation as many patients had already started taking antibiotics (Robertson et al., 1958).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Robertson et al., 1958 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the United Kingdom, of 457 fatalities in the 2009 pandemic, 68 were autopsied; 41% had complications associated with secondary bacterial infection, most commonly (25% of cases) due to S. pneumoniae.
“In the United Kingdom, of the 457 fatalities 68 were autopsied. Of these, 41% were shown to have complications associated with secondary bacterial infection, most commonly (25% of cases) due to S. pneumoniae (Lucas, 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lucas, 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBy the end of the 2009 pandemic, there were 284,000 deaths worldwide, with Mexico and the United States most severely affected.
“By the end of the pandemic it is thought that there were 284,000 deaths worldwide, with Mexico and the United States being most severely affected (Chertow and Memoli, 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chertow and Memoli, 2013
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationWorldwide 1-2 million people died during the 1968-1969 Hong Kong influenza pandemic, which was caused by influenza strain A(H3N2).
“Worldwide 1–2 million people died during this pandemic which was caused by the influenza strain A(H3N2) (Michaelis et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Michaelis et al., 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGlobal death toll estimates for the 1957 pandemic vary between 1.5 million and 2-4 million.
“Although global death toll estimates vary [between 1.5 million (Gatherer, 2009) and 2–4 million (Michaelis et al., 2009)]”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationDuring the 2009 Swine Flu Pandemic, almost 30% of the first 47 deaths in New York City showed invasive bacterial disease, with S. pneumoniae the most common causative agent.
“Surveillance by the New York City Department of Health and Mental Hygiene has shown that during the 2009 Swine Flu Pandemic almost 30% of the first 47 deaths showed invasive bacterial disease. S. pneumoniae was the most common causative agent identified (followed by S. pyogenes) (Lee E.H. et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lee E.H. et al., 2010
Not checked in the free run.
May combine two claims.
PremisecitationIn early influenza pandemics such as the 1918 Spanish pandemic, M. catarrhalis rarely appears to be a noted cause of co-infection, whereas in the 2009 pandemic it is seen in up to 18% of cases.
“In early influenza pandemics such as the 1918 Spanish pandemic, M. catarrhalis rarely appears to be a noted cause of co-infection. However, in the 2009 pandemic it is seen in up to 18% of cases (Nguyen et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nguyen et al., 2012 source
Not checked in the free run.
May combine two claims.
PremisecitationNon-pathogenic and mammalian influenza HA undergoes cleavage outside of the host cell, whereas highly pathogenic strains are cleaved inside host cells.
“Interestingly non-pathogenic and mammalian influenza HA undergoes cleavage outside of the host cell where as highly pathogenic strains are cleaved inside host cells (Steinhauer, 1999).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Steinhauer, 1999 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNeuraminidase enables release of newly formed progeny virions by hydrolysing sialic acid and detaching it from HA.
“Neuraminidase enables the release of newly formed progeny virions; by hydrolysing the sialic acid and detaching it from the HA the virion becomes liberated from the host cell (Zambon, 2001).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zambon, 2001 source
Not checked in the free run.
May combine two claims.
PremisecitationInfluenza, as well as other upper respiratory tract viral infections, leads to a greater risk of infection from bacterial pathobionts and an increased likelihood of colonization with bacteria such as S. pneumoniae, H. influenzae, and S. aureus.
“It has become clear that influenza, as well as other upper respiratory tract viral infections, leads not only to a greater risk of infection from bacterial pathobionts but also an increased likelihood that an individual may become colonized with bacteria such as S. pneumoniae, H. influenzae and S. aureus (Hament et al., 1999; Hilleman, 2002).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationIn a retrospective study of 50 patients infected during pandemic influenza, 28% showed co/secondary bacterial infection; Mycoplasma pneumoniae was found in 10%, S. aureus in 6%, K. pneumoniae and S. pneumoniae in 4%, and M. catarrhalis, P. aeruginosa, S. pyogenes, and Streptococcus agalactiae in 2%.
“In a retrospective study of 50 patients who were infected during pandemic influenza, 28% showed co/secondary bacterial infection (Dhanoa et al., 2011). Mycoplasma pneumoniae was found in 10%, making it the most common co/secondary infecting bacteria. This was followed by S. aureus found in 6%, K. pneumoniae and S. pneumoniae found in 4% and M. catarrhalis, P. aeruginosa, S. pyogenes, and Streptoc”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Dhanoa et al., 2011 source
Not checked in the free run.
May combine two claims.
PremisecitationInfluenza A is the type most commonly associated with co/secondary bacterial infection, and subtypes with NA2 traditionally result in more severe infection.
“Research shows that influenza A is the type most commonly associated with co/secondary bacterial infection and subtypes with NA2 traditionally result in more severe infection (Peltola et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Peltola et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationPoor disease outcome has been linked to lost lung repair function and loss of basal epithelial cells, including alveolar epithelial cells, which is associated with increased bacterial attachment and apoptosis.
“Furthermore, poor disease outcome has been linked to lost lung repair function and loss of basal epithelial cells, including alveolar epithelial cells; which is associated with increased bacterial attachment and apoptosis (Kash et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kash et al., 2011 source
Not checked in the free run.
May combine two claims.
PremisecitationIn another US pediatric intensive care unit study, 51% of children with influenza infection had bacterial co/secondary infection; of these 35% had S. aureus, 18% P. aeruginosa, 18% M. catarrhalis, 9% NTHI, 6% S. pneumoniae, and 6% Group A Streptococcus.
“In another study of vulnerable and critically ill children in a pediatric intensive care unit in the United States, 51% of those with influenza infection had bacterial co/secondary infection. Of these 35% presented with S. aureus, 18% P. aeruginosa, 18% M. catarrhalis, 9% NTHI, 6% S. pneumoniae and 6% Group A Streptococcus.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nguyen et al., 2012 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationM. catarrhalis is now acknowledged as the third most common cause of otitis media after S. pneumoniae and H. influenzae, and the second most common cause of exacerbations in COPD, accounting for up to 4 million exacerbations per year in the United States alone.
“Moraxella catarrhalis is a bacteria of increasing importance being now acknowledged as the third most common cause of otitis media (OM), after S. pneumoniae and H. influenzae (Bluestone, 1986; Faden et al., 1994; Kilpi et al., 2001; Dupont et al., 2010) and the second most common cause of exacerbations in COPD, accounting for up to 4 million exacerbations per year in the United States alone (Mur”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationSeasonal influenza A virus binds to α2-6 sialylated glycans on cells in the upper respiratory tract, whereas highly pathogenic avian H5N1 binds to α2-3 sialylated glycans on type 2 pneumocytes lining lung alveoli.
“traditionally seasonal influenza A virus binds to α2-6 sialylated glycans on cells in the upper respiratory tract whereas the highly pathogenic avian H5N1 strain binds to α2-3 sialylated glycans on type 2 pneumocytes lining lung alveoli (Shinya et al., 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Shinya et al., 2006 source
Not checked in the free run.
May combine two claims.
PremisecitationIn autopsies from the 1918 pandemic, S. pneumoniae was the most common co-infector, followed by S hemolytic, S. aureus, and H. influenzae; M. catarrhalis was grouped within 'Other bacteria'.
“For example, autopsies from the 1918 pandemic were reviewed and it was found that S. pneumoniae was the most common co-infector, followed by S hemolytic, S. aureus, and H. influenzae. ‘Other bacteria’ were also highlighted within which M. catarrhalis was grouped (Morens et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Morens et al., 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationThe low pH in the endosome causes a conformational change to HA allowing it to be cleaved, an important step in penetrating into the host cell; HA and availability of appropriate host proteases are determinants of infectivity.
“The low pH in the endosome causes a conformational change to the HA allowing it to be cleaved, an important step in penetrating into the host cell. Therefore HA and the availability of appropriate host proteases are determinants of infectivity (Steinhauer, 1999; Samji, 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Steinhauer, 1999 source
Not checked in the free run.
- cites Samji, 2009
Not checked in the free run.
May combine two claims.
PremisecitationIn that pediatric ICU study, those with S. aureus showed more severe morbidity and were more likely to develop disseminated intravascular coagulation.
“Those with S. aureus showed more severe morbidity and were more likely to develop disseminated intravascular coagulation which leads to a compromised blood flow within body tissue and therefore tissue damage (Nguyen et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nguyen et al., 2012 source
Not checked in the free run.
May combine two claims.
PremisereasoningVarious factors are known to impact the severity of viral infection, which in turn increases the likelihood of bacterial co/secondary infections; these include the type of HA and NA surface antigen.
“Various factors are known to impact the severity of viral infection, which in turn increases the likelihood of bacterial co/secondary infections; these include the type of HA and NA surface antigen.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationM. catarrhalis is a cause of pneumonia and invasive disease such as bacteraemia and meningitis, with bacteraemia being a common complication of pneumonia, particularly in adults.
“M. catarrhalis is a cause of pneumonia (Berg and Bartley, 1987; Hager et al., 1987; Marchant, 1990; Verduin et al., 2002) and invasive disease such as bacteraemia (Ioannidis et al., 1995) and meningitis (Newing and Christie, 1947), with bacteraemia being a common complication of pneumonia, particularly in adults (Collazos et al., 1992; Ioannidis et al., 1995).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationImpaired neutrophils correlate with secondary bacterial infection in chinchillas, due to the importance of phagocytosis during innate immunity.
“Impaired neutrophils have been shown to correlate with secondary bacterial infection in Chinchillas, due to the importance of phagocytosis during innate immunity (Abramson et al., 1981).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Abramson et al., 1981 source
Not checked in the free run.
May combine two claims.
PremisecitationInfluenza infection appears to prime host airways for bacterial infection and modifies and impairs immune responses in a number of ways.
“Influenza infection appears to prime the host airways for bacterial infection, whilst modifying and impairing immune responses in a number of ways (Joseph et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Joseph et al., 2013 source
Not checked in the free run.
May combine two claims.
PremisecitationDuring influenza infection, impaired immunologic cells can suppress host immune responses and immune cell dysfunction can reduce the host's ability to fight bacteria.
“host immune responses can be suppressed when immunologic cells are impaired during influenza infection and immune cell dysfunction can reduce the host’s ability to fight bacteria”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Peltola and McCullers, 2004
Not checked in the free run.
- cites Brundage, 2006 source
Not checked in the free run.
- cites Wu et al., 2011
Not checked in the free run.
May combine two claims.
PremisecitationPulmonary IFNγ pro-inflammatory cytokines are produced by natural killer (NK) cells as part of innate immunity and by CD4 and CD8 NK T cells as part of adaptive immunity.
“pulmonary IFNγ pro-inflammatory cytokines are produced by natural killer (NK) cells as part of innate immunity and by CD4 and CD8 NK T cells as part of adaptive immunity (Schoenborn and Wilson, 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Schoenborn and Wilson, 2007
Not checked in the free run.
May combine two claims.
PremisecitationType I IFN-mediated inhibition of Th17 immunity reduces CD4+ T cells and gamma delta T cells, leading to reduced production of IL-17 and IL-22 and preventing clearance of bacteria.
“and therefore there is a reduction in the levels of CD4+ T cells and gamma delta T cells and hence a reduction in the production of IL-17 and IL-22, preventing the clearance of bacteria (Shahangian et al., 2009; Kudva et al., 2011; Mulcahy and McLoughlin, 2016).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
InterpretationcitationThe reduction in alveolar macrophages during S. pneumoniae and influenza co-infection likely hinders bacterial clearance, leading to increased bacterial load and prolonged inflammatory response increasing morbidity.
“This reduction is likely to hinder bacterial clearance, hence the increased bacterial load found during co-infection during this study, and results in prolonged inflammatory response increasing morbidity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sharma-Chawla et al., 2016 source
Not checked in the free run.
May combine two claims.
PremisecitationInfluenza A virus can produce viral cytotoxin PB1-F2, which increases inflammation, host cell damage, bacterial adherence, mortality and morbidity.
“Influenza A virus can produce a viral cytotoxin PB1-F2 (Conenello and Palese, 2007; Iverson et al., 2011) which plays a role in increasing inflammation and therefore host cell damage and bacterial adherence, increasing mortality and morbidity (Lee et al., 2016).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
InterpretationcitationIL-1β plays a role in Th17 polarization, so decreased IL-1β further hinders Th17 immunity.
“IL-1β has been shown to play a role in Th17 polarization, therefore further hindering this pathway of immunity (Robinson et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Robinson et al., 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenInflammation causes tissue damage, revealing more attachment sites for increased/developed bacterial infection.
“Inflammation causes tissue damage, revealing more attachment sites for increased/developed bacterial infection.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDistress signals such as ATP and norepinephrine produced by damaged influenza instigate biofilm dispersal, helping spread of S. aureus into the lungs and assisting development of pneumonia and invasive disease.
“Distress signals, such as ATP and norepinephrine, produced by damaged influenza also have several effects on S. aureus; namely the instigation of biofilm dispersal which helps the spread of S. aureus into the lungs, assisting in the development of pneumonia and invasive disease (Mulcahy and McLoughlin, 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mulcahy and McLoughlin, 2016
Not checked in the free run.
May combine two claims.
InterpretationreasoningViral infection aids bacterial infection by unveiling/providing more sites for adhesion, impairing immune responses, and causing cell and tissue destruction allowing spread of bacteria and development of invasive infection.
“Viral infection aids bacterial infection in a number of ways, including unveiling/providing more sites for adhesion, impairing immune responses and causing cell and tissue destruction allowing for the spread of bacteria and development of invasive infection.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningWhen S. pneumoniae successively co-infects with influenza, it leads to severe clinical complications, partly due to increased apoptosis of dendritic cells, reducing T cell priming and impairing adaptive immunity.
“In addition, when S. pneumoniae successively co-infects with influenza it leads to severe clinical complications; partly due to an increase in apoptosis of dendritic cells, which therefore reduces T cell priming impairing the development of adaptive immunity.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIP-10 attracts various immune cells including activated T cells, monocytes and macrophages, causing inflammation.
“IP-10 attracts various immune cells including activated T cells, monocytes and macrophages, therefore causing inflammation (Dufour et al., 2002; Hoffmann et al., 2016).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationIL-22 is involved in controlling production of antimicrobial peptides and staphylococcal ligand expression.
“IL-22 in involved in controlling the production of antimicrobial peptides as well as staphylococcal ligand expression (Robinson et al., 2014; Mulcahy et al., 2016).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Robinson et al., 2014 source
Not checked in the free run.
- cites Mulcahy et al., 2016
Not checked in the free run.
May combine two claims.
PremisecitationIP-10 is increased during H. influenzae and S. aureus co-infection and correlates with pneumonia etiology.
“IP-10 is increased during H. influenzae and S. aureus co-infection as well, and like with S. pneumoniae, correlates with/highlights pneumonia etiology (Hoffmann et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hoffmann et al., 2016 source
Not checked in the free run.
The paper relies on this without support.
Antibiotic resistance is increasing.
“With increased antibiotic resistance and vaccine evasion it is important to monitor the epidemiology of pathogens in circulation to inform clinical treatment and development, particularly in the setting of an influenza epidemic/pandemic.”
“increasing levels of antibiotic resistance”
The paper relies on this without support.
Vaccine evasion occurs.
“With increased antibiotic resistance and vaccine evasion it is important to monitor the epidemiology of pathogens in circulation to inform clinical treatment and development, particularly in the setting of an influenza epidemic/pandemic.”
The paper relies on this without support.
Vaccine implementation is lower in low and middle income countries.
“lower levels of vaccine implementation in low and middle income countries”
The paper relies on this without support.
Pneumococcal vaccines have fractional serotype coverage.
“fractional serotype coverage”
The paper relies on this without support.
Antibiotic resistance is at an all-time high.
“with antibiotic resistance at an all-time high”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
One of the most feared consequences of influenza infection is secondary bacterial infection and resulting ARDS, due to the substantial increase in morbidity and mortality.
“One of the most feared consequences of influenza infection is secondary bacterial infection (this is bacterial infection that occurs during or after an infection from another pathogen; commonly viruses) (Morris et al., 2017) and resulting ARDS, due to the substantial increase in morbidity and mortality.”
From Viral Infections, the Microbiome, and Probiotics (2021) · cites this paper as Morris et al., 2017
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070 · cited 3× · see citing works
“When combined, lower and upper respiratory infections are the fourth highest cause of global mortality (Lozano et al., 2012).”
BackgroundGlobal trends in emerging infectious diseases
Jones, K. E., Patel, N. G., Levy, M. A., Storeygard, A., Balk, D., Gittleman, J. L., & Daszak, P. (2008) · Nature · doi:10.1038/nature06536 · Cited by 8,338 · see citing works
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,970 · see citing works
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192 · see citing works
Evolution and ecology of influenza A viruses
Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., & Kawaoka, Y. (1992) · Microbiological Reviews · doi:10.1128/mr.56.1.152-179.1992 · Cited by 4,739 · see citing works
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · see citing works
The role of nasal carriage in Staphylococcus aureus infections
Wertheim, H. F., Melles, D. C., Vos, M. C., van Leeuwen, W., van Belkum, A., Verbrugh, H. A., & Nouwen, J. L. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70295-4 · Cited by 2,685 · see citing works
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Van Vinh Chau, N., Khanh, T. H., Dong, V. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1477 · Cited by 1,858 · see citing works
Regulation of Interferon‐γ During Innate and Adaptive Immune Responses
Schoenborn, J. R., & Wilson, C. B. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)96002-2 · Cited by 1,659 · see citing works
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625 · cited 6× · see citing works
“There are many published examples of co/secondary bacterial infections during the 1918 influenza pandemic, and pneumonia as a consequence of bacterial infection is estimated to have occurred in up to 95% of deaths during this pandemic (Morens et al., 2008).”
BackgroundInfluentialRapid Evolution of RNA Genomes
Holland, J. J., Spindler, K. R., Horodyski, F. M., Grabau, E. A., Nichol, S. T., & VandePol, S. (1982) · Science · doi:10.1126/science.7041255 · Cited by 1,478 · see citing works
Influenza virus receptors in the human airway
Shinya, K., Ebina, M., Yamada, S., Ono, M., Kasai, N., & Kawaoka, Y. (2006) · Nature · doi:10.1038/440435a · Cited by 1,398 · see citing works
The Pathology of Influenza Virus Infections
Taubenberger, J. K., & Morens, D. M. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154316 · Cited by 1,111 · see citing works
A distinct lineage of influenza A virus from bats
Tong, S., Li, Y., Rivailler, P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116200109 · Cited by 1,106 · see citing works
Dufour, J. H., Dziejman, M., Liu, M. T., Leung, J. H., Lane, T. E., & Luster, A. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3195 · Cited by 1,075 · see citing works
Prediction and prevention of the next pandemic zoonosis.
Morse, S. S., Mazet, J. A., Woolhouse, M., Parrish, C. R., Carroll, D., Karesh, W. B., Zambrana-Torrelio, C., Lipkin, W. I., & Daszak, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61684-5 · Cited by 1,070 · see citing works
From Q Fever to Coxiella burnetii Infection: a Paradigm Change
Eldin, C., Melenotte, C., Mediannikov, O., Ghigo, É., Million, M., Edouard, S., Mège, J., Maurin, M., & Raoult, D. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00045-16 · Cited by 1,010 · see citing works
Ecology of zoonoses: natural and unnatural histories
Karesh, W. B., Dobson, A., Lloyd‐Smith, J. O., Lubroth, J., Dixon, M. A., Bennett, M. J., Aldrich, S., Harrington, T., Formenty, P., Loh, E. H., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61678-x · Cited by 950 · see citing works
Epidemiology and Outcomes of Health-care–Associated Pneumonia
Kollef, M. H., Shorr, A., Tabak, Y. P., Gupta, V., Liu, L. Z., & Johannes, R. S. (2005) · Chest · doi:10.1378/chest.128.6.3854 · Cited by 948 · see citing works
The Inflammatory Response to Cell Death
Rock, K. L., & Kono, H. (2007) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151456 · Cited by 945 · see citing works
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.
Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Hyun Kim, J., Halfmann, P., Hatta, M., et al. (2007) · Nature · doi:10.1038/nature05495 · Cited by 934 · see citing works
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930 · cited 1× · see citing works
“H. influenzae serotype B was a major cause of invasive disease (Wenger, 1998; Murphy, 2003; Chin et al., 2005; Brouwer et al., 2010) although widespread implementation of the Hib vaccine has significantly reduced the burden of disease (Rosenstein and Perkins, 2000).”
BackgroundGlobal Epidemiology of Influenza: Past and Present
Cox, N. J., & Subbarao, K. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.407 · Cited by 838 · see citing works
Genetic Analysis of the Capsular Biosynthetic Locus from All 90 Pneumococcal Serotypes
Bentley, S. D., Aanensen, D. M., Mavroidi, A., Saunders, D., Rabbinowitsch, E., Collins, M. D., Donohoe, K., Harris, D. J., Murphy, L., Quail, M. A., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020031 · Cited by 759 · see citing works
Cundell, D. R., Gerard, N. P., Gerard, C. J., Idänpään‐Heikkilä, I., & TUOMANEN, E. I. (1995) · Nature · doi:10.1038/377435a0 · Cited by 741 · see citing works
Role of hemagglutinin cleavage for the pathogenicity of influenza virus.
Steinhauer, D. A. (1999) · Virology · doi:10.1006/viro.1999.9716 · Cited by 663 · see citing works
Biggerstaff, M., Cauchemez, S., Reed, C., Gambhir, M., & Finelli, L. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-480 · Cited by 609 · see citing works
Sun, K., & Metzger, D. W. (2008) · Nature Medicine · doi:10.1038/nm1765 · Cited by 587 · see citing works
Potter, C. W. (2001) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2001.01492.x · Cited by 584 · see citing works
The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis.
Klein, E. Y., Monteforte, B., Gupta, A., Jiang, W., May, L., Hsieh, Y., & Dugas, A. (2016) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12398 · Cited by 574 · see citing works
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus
Kash, J. C., Tumpey, T. M., Proll, S. C., Carter, V., Perwitasari, O., Thomas, M. J., Basler, C. F., Palese, P., Taubenberger, J. K., García-Sastre, A., et al. (2006) · Nature · doi:10.1038/nature05181 · Cited by 551 · see citing works
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484 · see citing works
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice
Shahangian, A., Chow, E. K., Tian, X., Kang, J. R., Ghaffari, A., Liu, S. Y., Belperio, J. A., Cheng, G., & Deng, J. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35412 · Cited by 479 · see citing works
Shope, R. E. (1931) · Journal of Experimental Medicine · doi:10.1084/jem.54.3.373 · Cited by 470 · see citing works
Emerging Infections: Pandemic Influenza
Glezen, W. P. (1996) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017917 · Cited by 462 · see citing works
Manipulation of Host Cell Death Pathways during Microbial Infections
Lamkanfi, M., & Dixit, V. M. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.007 · Cited by 450 · see citing works
Discovery of a New Capsular Serotype (6C) within Serogroup 6 ofStreptococcus pneumoniae
Park, I. H., Pritchard, D. G., Cartee, R. T., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02199-06 · Cited by 428 · see citing works
Pulmonary Pathologic Findings of Fatal 2009 Pandemic Influenza A/H1N1 Viral Infections
Gill, J. R., Sheng, Z.-M., Ely, S. F., Guinee, D. G., Beasley, M. B., Suh, J., Deshpande, C., Mollura, D. J., Morens, D. M., Bray, M., et al. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.2.235 · Cited by 426 · see citing works
McCullers, J. A., & Rehg, J. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/341462 · Cited by 423 · see citing works
Osterhaus, A. D. M. E., Rimmelzwaan, G. F., Martina, B. E. E., Bestebroer, T. M., & Fouchier, R. A. M. (2000) · Science · doi:10.1126/science.288.5468.1051 · Cited by 415 · see citing works
Rice, T. W., Rubinson, L., Uyeki, T. M., Vaughn, F. L., John, B. B., Miller, R. R., Higgs, E., Randolph, A. G., Smoot, B. E., & Thompson, B. T. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182416f23 · Cited by 391 · see citing works
Bacterial Coinfection in Influenza: A Grand Rounds Review
Chertow, D. S., & Memoli, M. J. (2013) · JAMA · doi:10.1001/jama.2012.194139 · Cited by 390 · see citing works
Brundage, J. F. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70466-2 · Cited by 386 · see citing works
Role of Neuraminidase in Lethal Synergism between Influenza Virus and Streptococcus pneumoniae
McCullers, J. A., & Bartmess, K. C. (2003) · The Journal of Infectious Diseases · doi:10.1086/368163 · Cited by 384 · see citing works
Deaths from Bacterial Pneumonia during 1918–19 Influenza Pandemic
Brundage, J. F., & Shanks, G. D. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1408.071313 · Cited by 384 · see citing works
Bat-derived influenza-like viruses H17N10 and H18N11
Wu, Y., Wu, Y., Wu, Y., et al. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.01.010 · Cited by 366 · see citing works
Moraxella catarrhalis : from Emerging to Established Pathogen
Verduin, C. M., Hol, C., Fleer, A., van Dijk, H., & van Belkum, A. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.1.125-144.2002 · Cited by 353 · see citing works
Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950
Nakajima, K., Desselberger, U., & Palese, P. (1978) · Nature · doi:10.1038/274334a0 · Cited by 351 · see citing works
Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans
Peiris, M. J. S., Poon, L. L. M., & Guan, Y. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.06.006 · Cited by 348 · see citing works
Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice.
Kudva, A., Scheller, E. V., Robinson, K. M., Crowe, C. R., Choi, S. M., Slight, S. R., Khader, S. A., Dubin, P. J., Enelow, R. I., Kolls, J. K., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002194 · Cited by 346 · see citing works
Pai, R. B., Moore, M. R., Pilishvili, T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/498043 · Cited by 331 · see citing works
Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control.
HILLEMAN, M. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00254-2 · Cited by 319 · see citing works
Finelli, L., Fiore, A., Dhara, R., Brammer, L., Shay, D. K., Kamimoto, L., Fry, A., Hageman, J., Gorwitz, R., Bresee, J., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2008-1336 · Cited by 312 · see citing works
Influenza Vaccines: Challenges and Solutions
Houser, K. V., & Subbarao, K. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.02.012 · Cited by 311 · see citing works
Respiratory viral infection predisposing for bacterial disease: a concise review.
Hament, J.-M., Kimpen, J. L. L., Fleer, A., & Wolfs, T. F. W. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01389.x · Cited by 306 · see citing works
Influenza virus morphogenesis and budding
Nayak, D. P., Balogun, R. A., Yamada, H., Zhou, Z. H., & Barman, S. (2009) · Virus Research · doi:10.1016/j.virusres.2009.05.010 · Cited by 302 · see citing works
KILPI, T., HERVA, E., KAIJALAINEN, T., SYRJÄNEN, R., & TAKALA, A. K. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200107000-00004 · Cited by 299 · see citing works
Natural killer cell cytotoxicity: how do they pull the trigger?
Topham, N. J., & Hewitt, E. W. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03123.x · Cited by 298 · see citing works
Healthcare utilization and cost of pneumococcal disease in the United States
Huang, S. S., Johnson, K. M., Ray, G. T., Wroe, P. C., Lieu, T. A., Moore, M. R., Zell, E. R., Linder, J. A., Grijalva, C. G., Metlay, J. P., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.088 · Cited by 296 · see citing works
Metersky, M. L., Masterton, R. G., Lode, H., File, T. M., & Babinchak, T. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.01.003 · Cited by 293 · see citing works
Respiratory viruses predisposing to bacterial infections: role of neuraminidase.
PELTOLA, V. T., & MCCULLERS, J. A. (2004) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000108197.81270.35 · Cited by 290 · see citing works
Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease
Murphy, T. F., Brauer, A. L., Grant, B. J. B., & Sethi, S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200412-1747oc · Cited by 284 · see citing works
Clinical effectiveness of influenza vaccination in Manitoba.
Fedson, D. S. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510160074032 · Cited by 278 · see citing works
Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza
Palacios, G., Hornig, M., Cisterna, D., Savji, N., Bussetti, A. V., Kapoor, V., Hui, J., Tokarz, R., Briese, T., Baumeister, E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008540 · Cited by 275 · see citing works
Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine
Couch, R. B., Kasel, J. A., Gerin, J. L., et al. (1974) · The Journal of Infectious Diseases · doi:10.1093/infdis/129.4.411 · Cited by 259 · see citing works
Avian Influenza Virus Exhibits Rapid Evolutionary Dynamics
Chen, R., & Holmes, E. C. (2006) · Molecular Biology and Evolution · doi:10.1093/molbev/msl102 · Cited by 256 · see citing works
Branhamella catarrhalis: an organism gaining respect as a pathogen
Catlin, B. W. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.4.293 · Cited by 255 · see citing works
Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City
Olson, D. R., Simonsen, L., Edelson, P. J., & Morse, S. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408290102 · Cited by 251 · see citing works
Bacterial and viral infections associated with influenza
Joseph, C., Togawa, Y., & Shindo, N. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12089 · Cited by 250 · see citing works
The 1918 “Spanish Flu” in Spain
Trilla, A., Trilla, G., & Daer, C. (2008) · Clinical Infectious Diseases · doi:10.1086/590567 · Cited by 249 · see citing works
Siegel, S. J., Roche, A. M., & Weiser, J. N. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.06.005 · Cited by 247 · see citing works
Schwarzmann, S. W. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.1971.00310180053006 · Cited by 238 · see citing works
Plotkowski, M.-C., Puchelle, E., Beck, G., Jacquot, J., & Hannoun, C. (1986) · American Review of Respiratory Disease · doi:10.1164/arrd.1986.134.5.1040 · Cited by 231 · see citing works
The 2009 H1N1 influenza outbreak in its historical context.
Gatherer, D. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.06.004 · Cited by 227 · cited 2× · see citing works
“Asian influenza pandemic 1957– 1958 A(H2N2) Although global death toll estimates vary [between 1.5 million (Gatherer, 2009) and 2–4 million (Michaelis et al., 2009)], the death toll in the United States is accurately reported to have been 69, 800 (Klimov et al., 1999; Hilleman, 2002).”
BackgroundInfluentialYamashita, M., Krystal, M., Fitch, W. M., & Palese, P. (1988) · Virology · doi:10.1016/0042-6822(88)90238-3 · Cited by 223 · see citing works
Critically Ill Children During the 2009–2010 Influenza Pandemic in the United States
Randolph, A. G., Vaughn, F., Sullivan, R., Rubinson, L., Thompson, B. T., Yoon, G., Smoot, E., Rice, T. W., Loftis, L. L., Helfaer, M., et al. (2011) · Pediatrics · doi:10.1542/peds.2011-0774 · Cited by 222 · see citing works
Bucior, I., Pielage, J. F., & Engel, J. N. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002616 · Cited by 221 · cited 1× · see citing works
“For example the exposure of apical receptors like integrins permit the adhesion of bacteria such as S. aureus and P. aeruginosa (Sanford et al., 1978; Davison and Sanford, 1981; Bucior et al., 2012; Smith and McCullers, 2014).”
BackgroundInfluenza A: understanding the viral life cycle.
Samji, T. (2009) · PubMed · Cited by 220 · see citing works
Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
Peltola, V. T., Murti, K. G., & McCullers, J. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/430954 · Cited by 219 · see citing works
McCullers, J. A., McAuley, J. L., Browall, S., Iverson, A. R., Boyd, K. L., & Henriques Normark, B. (2010) · The Journal of Infectious Diseases · doi:10.1086/656333 · Cited by 218 · see citing works
Taubenberger, J. K., Reid, A. H., Janczewski, T. A., & Fanning, T. G. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.1020 · Cited by 209 · see citing works
BACTERIOLOGY AND HISTOPATHOLOGY OF THE RESPIRATORY TRACT AND LUNGS IN FATAL ASIAN INFLUENZA
Hers, J. F. P., Masurel, N., & Mulder, J. (1958) · The Lancet · doi:10.1016/s0140-6736(58)92404-8 · Cited by 201 · see citing works
Parrish, C. R., Murcia, P. R., & Holmes, E. C. (2014) · Journal of Virology · doi:10.1128/jvi.03146-14 · Cited by 197 · see citing works
The pathogenesis of influenza in humans.
Zambon, M. C. (2001) · Reviews in Medical Virology · doi:10.1002/rmv.319 · Cited by 186 · see citing works
Bacterial adherence to pharyngeal cells during viral infection.
Fainstein, V., Musher, D. M., & Cate, T. R. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/141.2.172 · Cited by 177 · see citing works
The Role of Viral, Host, and Secondary Bacterial Factors in Influenza Pathogenesis
Kash, J. C., & Taubenberger, J. K. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.08.030 · Cited by 176 · see citing works
Faden, H., Harabuchi, Y., Hong, J. J., & Pediatrics, T. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.6.1312 · Cited by 175 · see citing works
The 1918 Spanish influenza:integrating history and biology
Reid, A. H., Taubenberger, J. K., & Fanning, T. G. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01351-4 · Cited by 171 · see citing works
A New Pneumococcal Serotype, 11E, Has a Variably InactivatedwcjEGene
Calix, J. J., & Nahm, M. H. (2010) · The Journal of Infectious Diseases · doi:10.1086/653123 · Cited by 169 · see citing works
Abdullahi, O., Nyiro, J., Lewa, P., Slack, M., & Scott, J. A. G. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31814da70c · Cited by 168 · see citing works
Influenza virus primes mice for pneumonia from Staphylococcus aureus.
Iverson, A. R., Boyd, K. L., McAuley, J. L., Plano, L. R., Hart, M. E., & McCullers, J. A. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq113 · Cited by 168 · see citing works
Estimates of the US health impact of influenza.
Sullivan, K. M., Monto, A. S., & Longini, I. M. (1993) · American Journal of Public Health · doi:10.2105/ajph.83.12.1712 · Cited by 166 · see citing works
Respiratory infections caused by non-typeable Haemophilus influenzae.
Murphy, T. F. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200304000-00009 · Cited by 165 · see citing works
Jackson, C., Mangtani, P., Hawker, J. I., Olowokure, B., & Vynnycky, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097297 · Cited by 161 · see citing works
Branhamella catarrhalis respiratory infections.
Hager, H., Verghese, A., Alvarez, S., & Berk, S. L. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.6.1140 · Cited by 160 · see citing works
Hampson, A. W., & Mackenzie, J. S. (2006) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00705.x · Cited by 159 · see citing works
Dormitzer, P. R., Galli, G., Castellino, F., Golding, H., Khurana, S., Giudice, G. D., & Rappuoli, R. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00974.x · Cited by 158 · see citing works
WENGER, J. D. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199809001-00008 · Cited by 153 · see citing works
Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity.
Tashiro, M., Ciborowski, P., Reinacher, M., Pulverer, G., Klenk, H.-D., & Rott, R. (1987) · Virology · doi:10.1016/0042-6822(87)90284-4 · Cited by 152 · see citing works
Chin, C. L., Manzel, L. J., Lehman, E. E., Humlicek, A. L., Shi, L., Starner, T. D., Denning, G. M., Murphy, T. F., Sethi, S., & Look, D. C. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200412-1687oc · Cited by 151 · see citing works
Calix, J. J., Porambo, R. J., Brady, A. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.380451 · Cited by 149 · see citing works
Identifying the interaction between influenza and pneumococcal pneumonia using incidence data.
Shrestha, S., Foxman, B., Weinberger, D. M., Steiner, C., Viboud, C., & Rohani, P. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005982 · Cited by 148 · see citing works
Excess Deaths Attributable to Influenza in England and Wales: Age at Death and Certified Cause
TILLETT, H. E., SMITH, J. W. G., & GOOCH, C. D. (1983) · International Journal of Epidemiology · doi:10.1093/ije/12.3.344 · Cited by 146 · cited 2× · see citing works
“Overall 33,800 people died in the United States (Klimov et al., 1999) and England and Wales saw a 55% increase in respiratory deaths in 1969 (Tillett et al., 1983).”
BackgroundBacterial Pathogens and Death during the 1918 Influenza Pandemic
Chien, Y.-W., Klugman, K. P., & Morens, D. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0908216 · Cited by 143 · see citing works
Kash, J. C., Walters, K.-A., Davis, A. S., Sandouk, A., Schwartzman, L. M., Jagger, B. W., Chertow, D. S., Qi, L., Kuestner, R. E., Ozinsky, A., et al. (2011) · mBio · doi:10.1128/mbio.00172-11 · Cited by 143 · see citing works
World war I may have allowed the emergence of “Spanish” influenza.
Oxford, J., Sefton, A., Jackson, R., Innes, W., Daniels, R., & Johnson, N. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00185-8 · Cited by 139 · see citing works
Transmissibility and geographic spread of the 1889 influenza pandemic
Valleron, A., Cori, A., Valtat, S., Meurisse, S., Carrat, F., & Boëlle, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000886107 · Cited by 138 · see citing works
Baum, L. G., & Paulson, J. C. (1991) · Virology · doi:10.1016/0042-6822(91)90003-t · Cited by 136 · see citing works
Jin, P., Kong, F., Xiao, M., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/606118 · Cited by 136 · see citing works
Secondary Bacterial Infections in Influenza Virus Infection Pathogenesis
Smith, A. M., & McCullers, J. A. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_394 · Cited by 135 · see citing works
Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae.
Håkansson, A., Kidd, A., Wadell, G., Sabharwal, H., & Svanborg, C. (1994) · Infection and Immunity · doi:10.1128/iai.62.7.2707-2714.1994 · Cited by 134 · see citing works
Bench-to-bedside review: Bacterial pneumonia with influenza - pathogenesis and clinical implications
van der Sluijs, K. F., van der Poll, T., Lutter, R., Juffermans, N. P., & Schultz, M. J. (2010) · Critical Care · doi:10.1186/cc8893 · Cited by 133 · see citing works
Invasive Disease Caused by Nontypeable Haemophilus influenzae
Langereis, J. D., & de Jonge, M. I. (2015) · Emerging infectious diseases · doi:10.3201/eid2110.150004 · Cited by 132 · see citing works
Bacterial pneumonia and pandemic influenza planning.
Gupta, R. K., George, R., & Nguyen-Van-Tam, J. S. (2008) · Emerging infectious diseases · doi:10.3201/eid1408.070751 · Cited by 132 · see citing works
The immunology of influenza virus-associated bacterial pneumonia.
Robinson, K. M., Kolls, J. K., & Alcorn, J. F. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.02.002 · Cited by 132 · see citing works
Weinberger, D. M., Simonsen, L., Jordan, R., Steiner, C., Miller, M., & Viboud, C. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir749 · Cited by 132 · see citing works
Robinson, K. M., McHugh, K. J., Mandalapu, S., Clay, M. E., Lee, B., Scheller, E. V., Enelow, R. I., Chan, Y. R., Kolls, J. K., & Alcorn, J. F. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit527 · Cited by 131 · see citing works
Novel swine-origin influenza A virus in humans: another pandemic knocking at the door.
Michaelis, M., Doerr, H. W., & Cinatl, J. (2009) · Medical Microbiology and Immunology · doi:10.1007/s00430-009-0118-5 · Cited by 127 · see citing works
Robinson, K. M., Choi, S. M., McHugh, K. J., Mandalapu, S., Enelow, R. I., Kolls, J. K., & Alcorn, J. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301237 · Cited by 126 · see citing works
Fatalities Associated with the 2009 H1N1 Influenza A Virus in New York City
Lee, E. H., Wu, C., Lee, E. U., Stoute, A., Hanson, H., Cook, H. A., Nivin, B., Fine, A. D., Kerker, B. D., Harper, S. A., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/652446 · Cited by 126 · see citing works
Madhi, S. A., Adrian, P., Kuwanda, L., Cutland, C., Albrich, W. C., & Klugman, K. P. (2007) · The Journal of Infectious Diseases · doi:10.1086/522164 · Cited by 125 · see citing works
IMPORTANCE OF STAPHYLOCOCCUS AUREUS IN PNEUMONIA IN THE 1957 EPIDEMIC OF INFLUENZA A
Robertson, L., Caley, J. P., & Moore, J. (1958) · The Lancet · doi:10.1016/s0140-6736(58)90060-6 · Cited by 123 · see citing works
Li, Q., Sun, X., Li, Z., Liu, Y., Vavricka, C. J., Qi, J., & Gao, G. F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211037109 · Cited by 119 · see citing works
Unraveling the Mystery of Swine Influenza Virus
Wang, T. T., & Palese, P. (2009) · Cell · doi:10.1016/j.cell.2009.05.032 · Cited by 114 · see citing works
Okamoto, S., Kawabata, S., Nakagawa, I., Okuno, Y., Goto, T., Sano, K., & Hamada, S. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4104-4112.2003 · Cited by 114 · see citing works
Origin and progress of the 1968-69 Hong Kong influenza epidemic.
Cockburn, W. C., Delon, P. J., & Ferreira, W. (1969) · PubMed · Cited by 113 · see citing works
Bacterial adherence to virus-infected cells: a cell culture model of bacterial superinfection.
Sanford, B. A., Shelokov, A., & Ramsay, M. A. (1978) · Journal of Infectious Diseases · doi:10.1093/infdis/137.2.176 · Cited by 111 · see citing works
Bridy‐Pappas, A. E., Margolis, M. B., & Isaacman, D. J. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.9.1193 · Cited by 108 · see citing works
Archer, N. K., Harro, J. M., & Shirtliff, M. E. (2013) · Infection and Immunity · doi:10.1128/iai.00084-13 · Cited by 107 · see citing works
Diagnostic importance of relative lymphopenia as a marker of swine influenza (H1N1) in adults.
Cunha, B. A., Pherez, F. M., & Schoch, P. (2009) · Clinical Infectious Diseases · doi:10.1086/644496 · Cited by 104 · see citing works
Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969.
Schwarzmann, S. W., Jl, A., Rj, S., & Marine, W. M. (1971) · PubMed · Cited by 104 · see citing works
Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice.
Seki, M., Yanagihara, K., Higashiyama, Y., Fukuda, Y., Kaneko, Y., Ohno, H., Miyazaki, Y., Hirakata, Y., Tomono, K., Kadota, J., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00126103 · Cited by 103 · see citing works
Hong Kong Influenza: Clinical, Microbiologic, and Pathologic Features in 127 Cases
Lindsay, M. I. (1970) · JAMA · doi:10.1001/jama.1970.03180100019004 · Cited by 99 · see citing works
Murphy, F. A. (1998) · Emerging infectious diseases · doi:10.3201/eid0403.980324 · Cited by 97 · see citing works
Jacoby, P., Watson, K., Bowman, J., Taylor, A., Riley, T. V., Smith, D. W., & Lehmann, D. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.09.020 · Cited by 96 · cited 2× · see citing works
“pneumoniae, and colonization is a prerequisite for disease, so the presence of such co-infection fits with current knowledge (Jacoby et al., 2007; Abdullahi et al., 2008).”
BackgroundWadowsky, R. M., Mietzner, S. M., Skoner, D. P., Doyle, W. J., & Fireman, P. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1153-1157.1995 · Cited by 92 · see citing works
Disruption of Allosteric Response as an Unprecedented Mechanism of Resistance to Antibiotics
Fishovitz, J., Rojas-Altuve, A., Otero, L. H., Dawley, M. M., Carrasco‐López, C., Chang, M., Hermoso, J. A., & Mobashery, S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5030657 · Cited by 92 · see citing works
Pulmonary infections complicating Asian influenza.
PETERSDORF, R. G. (1959) · Archives of Internal Medicine · doi:10.1001/archinte.1959.00270020090010 · Cited by 91 · see citing works
A Postinfluenza Model of<i>Staphylococcus aureus</i>Pneumonia
Lee, M., Arrecubieta, C., Martin, F. J., Prince, A., Borczuk, A. C., & Lowy, F. D. (2010) · The Journal of Infectious Diseases · doi:10.1086/650204 · Cited by 90 · see citing works
Polymorphonuclear leukocyte dysfunction during influenza virus infection in chinchillas.
Abramson, J. S., Giebink, G. S., Mills, E. L., & Quie, P. G. (1981) · Journal of Infectious Diseases · doi:10.1093/infdis/143.6.836 · Cited by 88 · see citing works
Murray, R. J., Robinson, J. O., White, J. N., Hughes, F., Coombs, G. W., Pearson, J. C., Tan, H.-L., Chidlow, G., Williams, S., Christiansen, K. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008705 · Cited by 84 · see citing works
Bronchopulmonary infection due to Branhamella catarrhalis.
McLeod, D. T., Ahmad, F., Power, J. T., et al. (1983) · BMJ · doi:10.1136/bmj.287.6403.1446 · Cited by 84 · see citing works
Staphylococcus aureus and Influenza A Virus: Partners in Coinfection
Mulcahy, M. E., & McLoughlin, R. M. (2016) · mBio · doi:10.1128/mbio.02068-16 · Cited by 80 · see citing works
Branhamella (Neisseria) catarrhalis--a lower respiratory tract pathogen?
Johnson, M. A., Drew, W., & Roberts, M. C. (1981) · Journal of Clinical Microbiology · doi:10.1128/jcm.13.6.1066-1069.1981 · Cited by 78 · see citing works
Davison, V. E., & Sanford, B. A. (1981) · Infection and Immunity · doi:10.1128/iai.32.1.118-126.1981 · Cited by 75 · see citing works
Grijalva, C. G., Griffin, M. R., Edwards, K. M., Williams, J. V., Gil, A. I., Verastegui, H., Hartinger, S. M., Vidal, J. E., Klugman, K. P., & Lanata, C. F. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu148 · Cited by 72 · see citing works
Eom, S., Lee, D.-S., Jung, Y.-J., Park, J., Choi, J.-I., Yim, M., Jeon, J.-M., Kim, H., Son, K.-T., Je, J., et al. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-6041-8 · Cited by 71 · see citing works
Otitis media and sinusitis in children. Role of Branhamella catarrhalis.
Bluestone, C. D. (1986) · Drugs · doi:10.2165/00003495-198600313-00029 · Cited by 70 · see citing works
A Mouse Model of Lethal Synergism Between Influenza Virus and Haemophilus influenzae
Lee, L. N., Dias, P. B., Han, D., Yoon, S., Shea, A., Zakharov, V., Parham, D. M., & Sarawar, S. R. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090596 · Cited by 69 · see citing works
Influenza A Virus PB1-F2: A Small Protein with a Big Punch
Conenello, G. M., & Palese, P. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.010 · Cited by 68 · see citing works
Fatal Neisseria (Branhamella) catarrhalis pneumonia in an immunodeficient host.
McNeely, D. J., Kitchens, C. S., & Kluge, R. (1976) · PubMed · doi:10.1164/arrd.1976.114.2.399 · Cited by 65 · see citing works
Abrahams, A., Hallows, N., & French, H. (1919) · The Lancet · doi:10.1016/s0140-6736(01)22115-1 · Cited by 64 · see citing works
The Significance of Nongonococcal, Nonmeningococcal Neisseria Isolates from Blood Cultures
Feder, H. M., & Garibaldi, R. A. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.2.181 · Cited by 63 · see citing works
Sharma-Chawla, N., Sender, V., Kershaw, O., Gruber, A. D., Volckmar, J., Henriques-Normark, B., Stegemann-Koniszewski, S., & Bruder, D. (2016) · Infection and Immunity · doi:10.1128/iai.00422-16 · Cited by 63 · see citing works
Dunn, F. L. (1958) · JAMA · doi:10.1001/jama.1958.02990100028006 · Cited by 60 · see citing works
Matsuzaki, Y., Sugawara, K., Mizuta, K., et al. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.2.422-429.2002 · Cited by 60 · see citing works
Peckham, R. S. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316026939 · Cited by 60 · see citing works
Mulcahy, M. E., Leech, J. M., Renauld, J.-C., Mills, K. H., & McLoughlin, R. M. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.24 · Cited by 58 · see citing works
Surveillance and impact of influenza in the United States.
Klimov, A., Simonsen, L., Fukuda, K., & Cox, N. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00104-8 · Cited by 57 · see citing works
Pneumococcal vaccines for children: a global public health priority
Pittet, L. F., & Posfay-Barbe, K. M. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03938.x · Cited by 57 · see citing works
UPDATE ON HAEMOPHILUS INFLUENZAE SEROTYPE b AND MENINGOCOCCAL VACCINES
Rosenstein, N. E., & Perkins, B. A. (2000) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70210-8 · Cited by 55 · see citing works
Spectrum and Significance of Bacteremia Due to Moraxella catarrhalis
Ioannidis, J. P. A., Worthington, M., Griffiths, J. K., et al. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.2.390 · Cited by 55 · see citing works
Berendt, R. F., Long, G. G., & Walker, J. S. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/132.6.689 · Cited by 55 · see citing works
Nguyen, T., Kyle, U. G., Jaimon, N., Tcharmtchi, M. H., Coss-Bu, J. A., Lam, F., Teruya, J., & Loftis, L. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318260c7f8 · Cited by 54 · see citing works
Kleinerman, E. S., Daniels, C. A., Polisson, R. P., & D, R. S. M. (1976) · PubMed Central · Cited by 53 · see citing works
SCOTT, M. J., HOTH, J. J., STAGNER, M. K., GARDNER, S. A., PEYTON, J. C., & CHEADLE, W. G. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02547.x · Cited by 53 · see citing works
Hoffmann, J., Machado, D., Terrier, O., Pouzol, S., Messaoudi, M., Basualdo, W., Espínola, E. E., Guillen, R. M., Rosa-Calatrava, M., Picot, V., et al. (2016) · Scientific Reports · doi:10.1038/srep38532 · Cited by 53 · see citing works
Aebi, T., Weisser, M., Bucher, E., Hirsch, H. H., Marsch, S., & Siegemund, M. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-308 · Cited by 51 · see citing works
Why is coinfection with influenza virus and bacteria so difficult to control?
Cauley, L. S., & Vella, A. T. (2015) · PubMed · Cited by 49 · see citing works
The Russian Influenza in the United Kingdom, 1889–1894
SMITH, F. B. (1995) · Social History of Medicine · doi:10.1093/shm/8.1.55 · Cited by 48 · see citing works
Bacterial Adherence to the Upper Respiratory Tract of Ferrets Infected with Influenza A Virus
Sanford, B. A., & Ramsay, M. A. (1987) · Experimental Biology and Medicine · doi:10.3181/00379727-185-42525 · Cited by 45 · see citing works
Dupont, D., Mahjoub‐Messai, F., Francois, M., et al. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.04.012 · Cited by 45 · see citing works
Marchant, C. D. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90255-c · Cited by 45 · see citing works
Dhanoa, A., Fang, N. C., Hassan, S. S., Kaniappan, P., & Rajasekaram, G. (2011) · Virology Journal · doi:10.1186/1743-422x-8-501 · Cited by 45 · see citing works
Lee, S.-E., Eick, A., Bloom, M. S., & Brundage, J. F. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.041 · Cited by 44 · see citing works
Kash, J. C., Xiao, Y., Davis, A. S., Walters, K.-A., Chertow, D. S., Easterbrook, J. D., Dunfee, R. L., Sandouk, A., Jagger, B. W., Schwartzman, L. M., et al. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.014 · Cited by 43 · see citing works
Beyond the Cut Hunter: A Historical Epidemiology of HIV Beginnings in Central Africa
Rupp, S., Ambata, P., Narat, V., & Giles‐Vernick, T. (2016) · EcoHealth · doi:10.1007/s10393-016-1189-6 · Cited by 43 · see citing works
Model for studying bacterial adherence to epithelial cells infected with viruses.
Selinger, D. S., Reed, W. P., & McLaren, L. C. (1981) · Infection and Immunity · doi:10.1128/iai.32.2.941-944.1981 · Cited by 38 · see citing works
Daszak, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61887-x · Cited by 37 · see citing works
Mccullers, J. A., Iverson, A. R., Mckeon, R., & Murray, P. J. (2008) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701477568 · Cited by 36 · see citing works
Pneumonia associated with Branhamella catarrhalis in infants
Berg, R. A., & Bartley, D. L. (1987) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198706000-00017 · Cited by 35 · see citing works
Efficacy of 2'-deoxy-2'-fluororibosides against influenza A and B viruses in ferrets
Jakeman, K. J., Tisdale, M., Russell, S. M., et al. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1864 · Cited by 34 · see citing works
Potentiation of experimental meningitis due to Haemophilus influenzae by influenza A virus.
Michaels, R. H., Myerowitz, R. L., & Klaw, R. (1977) · Journal of Infectious Diseases · doi:10.1093/infdis/135.4.641 · Cited by 34 · see citing works
Moraxella catarrhalis bacteremic pneumonia in adults: Two cases and review of the literature
Collazos, J., Miguel, J. F. S., & Ayarza, R. (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02098086 · Cited by 31 · see citing works
Pai, R. B., Gertz, R. E., Whitney, C. G., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5440-5444.2005 · Cited by 30 · see citing works
Wu, Y., Mao, H., Ling, M.-T., Chow, K., Ho, P., Tu, W., & Lau, Y. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-201 · Cited by 29 · see citing works
Rizzo, C., Caporali, M. G., & Rota, M. C. (2010) · Clinical Infectious Diseases · doi:10.1086/653444 · Cited by 29 · see citing works
Lucas, S. (2010) · Health Technology Assessment · doi:10.3310/hta14550-02 · Cited by 28 · see citing works
Summary report on the Asian influenza epidemic in Japan, 1957.
FUKUMI, H. (1959) · PubMed · Cited by 26 · see citing works
Pulmonary clearance and phagocytic cell response to normal pharyngeal flora.
Onofrio, J. M., Shulkin, A. N., Heidbrink, P. J., et al. (1981) · PubMed · doi:10.1164/arrd.1981.123.2.222 · Cited by 24 · see citing works
Some aspects of the epidemiology of the 1957 influenza pandemic.
Payne, A. M.-M. (1958) · PubMed · Cited by 22 · see citing works
Emerging respiratory tract infections
Zumla, A. I., Hui, D. S. C., Al‐Tawfiq, J. A., Gautret, P., McCloskey, B., & Memish, Z. A. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70899-0 · Cited by 20 · see citing works
MICHAEL, M. (1942) · Journal of the American Medical Association · doi:10.1001/jama.1942.02830110011004 · Cited by 20 · see citing works
[Distribution of influenza C virus infection in dogs and pigs in Bavaria].
Youzbashi, E., Marschall, M., Chaloupka, I., & Meier-Ewert, H. (1996) · PubMed · Cited by 19 · see citing works
Takase, H., Nitanai, H., Yamamura, E., & Otani, T. (1999) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1999.tb01226.x · Cited by 18 · see citing works
Yang, M., Gao, H., Chen, J., Xu, X., Tang, L., Yang, Y., Liang, W., Yu, L., Sheng, J., & Li, L. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.10.018 · Cited by 17 · see citing works
Pandemic “influenza” and secondary pneumonia at camp fremont, Calif.
BREM, W. V. (1918) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1918.26020520007010b · Cited by 17 · see citing works
A BACTERIOLOGIC STUDY OF THE INFLUENZA EPIDEMIC AT CAMP DEVENS, MASS.
SPOONER, L. H. (1919) · Journal of the American Medical Association · doi:10.1001/jama.1919.02610030001001 · Cited by 16 · see citing works
Flagged first, then by citations
Research works printed but not linked: 5
- Johnson, 2016, The Spanish Flu Pandemic of 1918.
- Opie, 1921, The pneumonias and other infections of the respiratory tract accompanying influenza and measles. St. Louis: CV Mosby, Epidemic Respiratory Disease, 107
- Racaniello, 2009, The A, B, and C of Influenza Virus.
- 2016, Influenza (Seasonal) Factsheet.
- 2017, Smallpox.
Cited by
Sorted by citations
Viral Infections, the Microbiome, and Probiotics
Harper, A., Vijayakumar, V., Ouwehand, A. C., ter Haar, J., Obis, D., Espadaler, J., Binda, S., Desiraju, S., & Day, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.596166 · Cited by 177 · see citing works
Overcoming immune dysfunction in the elderly: trained immunity as a novel approach
Bulut, O., Kilic, G., Domínguez-Andrés, J., & Netea, M. G. (2020) · International Immunology · doi:10.1093/intimm/dxaa052 · Cited by 99 · see citing works
- Authors
- Morris, D. E., Cleary, D. W., & Clarke, S. C.
- Affiliations
- University Hospital Southampton NHS Foundation Trust (GB)
- Corresponding author
- Morris, Denise E.
- Clarke, Stuart C.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2017-06-23
- Volume
- 8
- Pages
- 1041-1041
- ISSN
- 1664-302X (ISSN-L)
- PMC
- PMC5481322
- OpenAlex
- W2718738457
- Semantic Scholar
- d292c61e7f79b50cb0c488b3d362ea9e6aa10310
- Cited by
- 576
- References
- 210
- Citations by year
- 2026: 28 · 2025: 45 · 2024: 77 · 2023: 95 · 2022: 90 · 2021: 109 · 2020: 76 · 2019: 25 · 2018: 17 · 2017: 1
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Microbiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- National University of Singapore (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- secondary bacterial infection, pandemic influenza, Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, bacterial co-infection, respiratory infections, antibiotic resistance, vaccine evasion, pathogen epidemiology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review